Xerium (XRM) Inactive 10-Q4 Nov 152015 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2015	Nov. 02, 2015
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	XRM
Entity Registrant Name	XERIUM TECHNOLOGIES INC
Entity Central Index Key	1,287,151
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		15,739,259

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 10,704	$ 9,517
Accounts receivable, net	77,813	83,069
Inventories, net	71,803	83,550
Prepaid expenses	8,275	8,472
Other current assets	16,118	15,714
Total current assets	184,713	200,322
Property and equipment, net	296,570	303,617
Goodwill	61,176	61,927
Intangible assets	9,126	11,707
Non-current deferred tax asset	9,555	10,662
Other assets	9,098	5,809
Total assets	570,238	594,044
Current liabilities:
Notes payable	6,742	244
Accounts payable	37,972	41,827
Accrued expenses	57,994	56,109
Current maturities of long-term debt	10,887	4,406
Total current liabilities	113,595	102,586
Long-term debt, net of current maturities	466,687	460,840
Liabilities under capital leases	5,067	3,945
Non-current deferred tax liability	7,891	10,416
Pension, other post-retirement and post-employment obligations	71,150	80,471
Other long-term liabilities	$ 13,099	$ 9,896
Commitments and contingencies
Stockholders’ deficit
Preferred stock, $0.001 par value, 1,000,000 shares authorized; no shares outstanding as of September 30, 2015 and December 31, 2014	$ 0	$ 0
Common stock, $0.001 par value, 20,000,000 shares authorized; 15,739,259 and 15,560,627 shares outstanding as of September 30, 2015 and December 31, 2014, respectively	16	16
Paid-in capital	429,445	428,880
Accumulated deficit	(415,123)	(417,068)
Accumulated other comprehensive loss	(121,589)	(85,938)
Total stockholders’ deficit	(107,251)	(74,110)
Total liabilities and stockholders’ deficit	$ 570,238	$ 594,044

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares outstanding (in shares)	15,739,259	15,560,627

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement [Abstract]
Net Sales	$ 117,739	$ 138,858	$ 361,896	$ 411,965
Costs and expenses:
Cost of products sold	71,252	83,364	217,413	248,954
Selling	15,889	18,195	48,645	55,362
General and administrative	14,370	14,133	40,261	43,337
Research and development	1,841	1,909	5,695	5,899
Restructuring	5,001	3,466	12,734	15,712
Costs and expenses	108,353	121,067	324,748	369,264
Income from operations	9,386	17,791	37,148	42,701
Interest expense, net	(9,775)	(9,412)	(28,144)	(26,985)
Foreign exchange gain (loss)	2,059	367	2,150	(818)
Income before provision for income taxes	1,670	8,746	11,154	14,898
Provision for income taxes	(755)	(29,218)	(9,209)	(33,440)
Net income (loss)	915	(20,472)	1,945	(18,542)
Comprehensive loss	$ (11,012)	$ (41,003)	$ (33,706)	$ (39,482)
Net income (loss) per share:
Basic (in dollars per share)	$ 0.06	$ (1.32)	$ 0.12	$ (1.20)
Diluted (in dollars per share)	$ 0.06	$ (1.32)	$ 0.12	$ (1.20)
Shares used in computing net income (loss) per share:
Basic (in shares)	15,667,103	15,475,836	15,595,793	15,426,125
Diluted (in shares)	16,567,070	15,475,836	16,440,525	15,426,125

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities
Net income (loss)	$ 1,945	$ (18,542)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation	2,690	1,858
Depreciation	21,397	24,950
Amortization of intangibles	228	1,230
Deferred financing cost amortization	2,641	2,409
Foreign exchange gain on revaluation of debt	(2,115)	(340)
Deferred taxes	(1,571)	1,509
Asset impairment	1,178	277
Gain on disposition of property and equipment	(85)	(4)
Provision for doubtful accounts	857	284
Change in assets and liabilities which provided (used) cash:
Accounts receivable	(2,789)	(5,047)
Inventories	3,640	(7,897)
Prepaid expenses	(717)	120
Other current assets	(2,025)	1,223
Accounts payable and accrued expenses	5,133	3,587
Deferred and other long-term liabilities	(5,551)	(4,300)
Net cash provided by operating activities	24,856	1,317
Investing activities
Capital expenditures	(40,376)	(33,666)
Proceeds from disposals of property and equipment	104	163
Net cash used in investing activities	(40,272)	(33,503)
Financing activities
Proceeds from borrowings	64,187	73,579
Principal payments on debt	(45,573)	(44,834)
Payment of financing fees	(18)	(1,398)
Payment of obligations under capital leases	(887)	(634)
Net cash provided by financing activities	17,709	26,713
Effect of exchange rate changes on cash flows	(1,106)	(430)
Net increase (decrease) in cash	1,187	(5,903)
Cash and cash equivalents at beginning of period	9,517	25,716
Cash and cash equivalents at end of period	10,704	19,813
Non-cash capitalized lease asset and liability	1,122	4,468
Accrued construction in process	$ 1,952	$ 2,400

Description of Business and Sig

Description of Business and Significant Accounting Policies	9 Months Ended
Description of Business and Significant Accounting Policies	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Significant Accounting Policies	Description of Business and Significant Accounting Policies Description of Business Xerium Technologies, Inc. (the "Company") is a leading global provider of industrial consumables and mechanical services used in the production of paper, paperboard, building products and nonwoven materials. Its operations are strategically located in the major paper-making regions of the world, including North America, Europe, South America and Asia-Pacific. Basis of Presentation The accompanying unaudited condensed consolidated interim financial statements at September 30, 2015 and for the three and nine months ended September 30, 2015 and 2014 include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) for interim financial reporting and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, such financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. The interim results presented herein are not necessarily indicative of the results to be expected for the entire year. In management’s opinion, these unaudited condensed consolidated interim financial statements contain all adjustments of a normal recurring nature necessary for a fair presentation of the financial statements for the interim periods presented. These unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2014 as reported on the Company's Annual Report on Form 10-K filed on March 4, 2015. Accounting Policies Inventories, net Inventories are generally valued at the lower of cost or market using the first-in, first-out (FIFO) method. Raw materials are valued principally on a weighted average cost basis. The Company’s work in process and finished goods are specifically identified and valued based on actual inputs to production. Provisions are recorded as appropriate to write-down obsolete and excess inventory to estimated net realizable value. The process for evaluating obsolete and excess inventory often requires management to make subjective judgments and estimates concerning future sales levels, quantities and prices at which such inventory will be able to be sold in the normal course of business, while considering the general aging of inventory and factoring in any new business conditions. The components of inventories are as follows at: September 30, December 31, Raw materials $ 12,383 $ 18,018 Work in process 26,055 28,756 Finished goods (includes consigned inventory of $6,985 at September 30, 2015 and $8,582 at December 31, 2014) 39,546 43,072 Inventory allowances (6,181 ) (6,296 ) $ 71,803 $ 83,550 Goodwill The Company accounts for goodwill and other intangible assets in accordance with ASC Topic 350, Intangibles—Goodwill and Other Intangible Assets (“Topic 350”). Topic 350 requires that goodwill and intangible assets that have indefinite lives not be amortized, but instead, must be tested for impairment at least annually or whenever events or business conditions warrant. During the nine months ended September 30, 2015 , the Company evaluated events and business conditions to determine if a test for an impairment of goodwill was warranted. No such events or business conditions took place during this period, therefore no test was determined to be warranted at September 30, 2015 . Warranties The Company offers warranties on certain roll products that it sells. The specific terms and conditions of these warranties vary depending on the product sold, the country in which the product is sold and arrangements with the customer. The Company estimates the costs that may be incurred under its warranties and records a liability in Accrued Expenses on its Consolidated Balance Sheet for such costs. Factors that affect the Company’s warranty liability include the number of units sold, historical and anticipated rates of warranty claims, cost per claim and new product introduction. The Company periodically assesses the adequacy of its recorded warranty claims and adjusts the amounts as necessary. The table below represents the changes in the Company’s warranty liability for the nine months ended September 30, 2015 and 2014: Beginning Balance Charged to Cost of Sales Effect of Foreign Currency Translation Deduction from Reserves Ending Balance Nine Months Ended September 30, 2015: $ 2,685 $ 1,184 $ (144 ) $ (1,580 ) $ 2,145 Nine Months Ended September 30, 2014: $ 1,629 $ 1,694 $ (86 ) $ (867 ) $ 2,370 Net (Loss) Income Per Common Share Net (loss) income per common share has been computed and presented pursuant to the provisions of ASC Topic 260, Earnings per Share (“Topic 260”). Net (loss) income per share is based on the weighted-average number of shares outstanding during the period. As of September 30, 2015 and 2014, the Company had outstanding restricted stock units (“RSUs”), deferred stock units (“DSUs”) and options. The following table sets forth the computation of basic and diluted weighted-average shares: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Weighted-average common shares outstanding–basic 15,667,103 15,475,836 15,595,793 15,426,125 Dilutive effect of stock-based compensation awards outstanding 899,967 — 844,732 — Weighted-average common shares outstanding–diluted 16,567,070 15,475,836 16,440,525 15,426,125 The following table sets forth the aggregate of the dilutive securities that were outstanding in the three and nine months ended September 30, 2015 and 2014, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Anti-dilutive securities 24,002 1,313,627 20,237 1,313,627 Impairment The Company reviews its long-lived assets that have finite lives for impairment in accordance with ASC Topic 360, Property, Plant, and Equipment (“Topic 360”). This topic requires that companies evaluate the fair value of long-lived assets based on the anticipated undiscounted future cash flows to be generated by the assets when indicators of impairment exist to determine if there is impairment to the carrying value. Any change in the carrying amount of an asset as a result of the Company's evaluation has been recorded in either restructuring expense, if it was a result of the Company's restructuring activities, or general and administrative expense for all other impairments in the consolidated statements of operations. For the nine months ended September 30, 2015 and 2014, the Company had $1.0 million and $0.3 million of impairment charges included in restructuring expense. Impairment charges associated with restructuring are discussed in Note 7 "Restructuring Expense". New Accounting Pronouncements In May of 2014, the FASB issued Accounting Standard Update No. 2014-09 Revenue from Contracts with Customers ("ASU 2014-09"). ASU 2014-09 requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company identify the contract with the customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract and recognize revenue when it satisfies the performance obligations. The Company will also be required to disclose information regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is required to be adopted in January of 2018. Retrospective application is required either to all periods presented or with the cumulative effect of initial adoption recognized in the period of adoption. The Company is in the process of evaluating this accounting standard update. In April of 2015, the FASB issued Accounting Standard Update No. 2015-03 Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs ("ASU 2015-03"). ASU 2015-03 requires debt issuance costs related to a recognized debt liability be presented on the balance sheet as a direct deduction from the carrying value of the debt liability, consistent with debt discounts. ASU 2015-03 is required to be adopted in January of 2016. The Company will adopt this pronouncement at December 31, 2015, and believes that the adoption of ASU 2015-03 will not have a material impact on its consolidated financial statements.

Derivatives and Hedging

Derivatives and Hedging	9 Months Ended
Derivatives and Hedging	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives and Hedging	Derivatives and Hedging Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. From time to time, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known cash amounts, the value of which are determined by interest rates or foreign exchange rates. Cash Flow Hedges of Interest Rate Risk From time to time, the Company uses interest rate derivatives to add stability to interest expense and to manage its exposure to interest rate movements. However, at September 30, 2015 , the Company had no interest rate swaps. Non-designated Hedges of Foreign Exchange Risk Derivatives not designated as hedges are not speculative and are used to manage the Company’s exposure to foreign exchange rates, but do not meet the strict hedge accounting requirements of ASC Topic 815. Changes in the fair value of derivatives not designated in hedging relationships are recorded directly in earnings. The Company, from time to time, may enter into foreign exchange forward contracts to fix currencies at specified rates based on expected future cash flows to protect against the fluctuations in cash flows resulting from sales denominated in foreign currencies. Additionally, to manage its exposure to fluctuations in foreign currency on intercompany balances and certain purchase commitments, the Company from time to time may use foreign exchange forward contracts. As of September 30, 2015 and December 31, 2014 , the Company had outstanding derivatives that were not designated as hedges in qualifying hedging relationships. The value of these contracts is recognized at fair value based on market exchange forward rates and is recorded in other assets or other liabilities on the Consolidated Balance Sheets. The following represents the fair value of these derivatives at September 30, 2015 and December 31, 2014 and the change in fair value included in foreign exchange gain in the three and nine months ended September 30, 2015 and 2014: September 30, 2015 December 31, 2014 Fair value of derivative asset (liability) $ 237 $ (524 ) Three Months Ended September 30, 2015: Three Months Ended September 30, 2014: Change in fair value of derivative included in foreign exchange loss $ (743 ) $ (123 ) Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Change in fair value of derivative included in foreign exchange loss $ (2,197 ) $ (1,328 ) The following represents the notional amounts of foreign exchange forward contracts at September 30, 2015 : Notional Sold Notional Purchased Non-designated hedges of foreign exchange risk $ 5,212 $ (38,814 ) Fair Value of Derivatives Under ASC Topic 820 ASC Topic 820, Fair Value Measurements and Disclosures (“Topic 820”), emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, Topic 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs including fair value of investments that do not have the ability to redeem at net asset value as of the measurement date, or during the first quarter following the measurement date. The derivative assets or liabilities are typically based on an entity’s own assumptions, as there is little, if any, market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and the Company considers factors specific to the asset or liability. The Company determined that its derivative valuations, which are based on market exchange forward rates, fall within Level 2 of the fair value hierarchy.

Long term Debt

Long term Debt	9 Months Ended
Long term Debt	Sep. 30, 2015
Debt Disclosure [Abstract]
Long term Debt	Long term Debt At September 30, 2015 and December 31, 2014 , long term debt consisted of the following: September 30, 2015 December 31, 2014 Senior secured term loan facility, payable quarterly, U.S. Dollar denominated–LIBOR $ 224,475 $ 226,052 Senior Notes (Unsecured), payable semi-annually–U.S. Dollar denominated interest rate fixed at 8.875%. Matures June of 2018. 236,410 236,410 Notes payable, working capital loan, variable interest rate at 1.75%. Matures June 30, 2016, with one-year rollover option. 6,742 244 Fixed asset loan contract, variable interest rate of 5.78%. Matures June of 2020. 7,497 — Other debt 9,192 2,784 Total debt 484,316 465,490 Less current maturities of long term debt and notes payable 17,629 4,650 Total long term debt $ 466,687 $ 460,840 On May 17, 2013, the Company entered into a Credit and Guaranty Agreement for a $200.0 million term loan credit facility (the “Term Credit Facility”), net of a discount of $1.0 million , among the Company, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions. The Company also entered into a Revolving Credit and Guaranty Agreement originally for a $40.0 million asset-based revolving credit facility subject to a borrowing base among Xerium Technologies, Inc., as a US borrower, Xerium Canada Inc., as Canadian borrower, certain direct and indirect U.S. subsidiaries of the Company as guarantors and certain financial institutions (the "Domestic Revolver"). On March 3, 2014, the Company entered into an amendment to the Revolving Credit and Guaranty Agreement (as amended, the “ABL Facility,” and collectively with the Term Credit Facility, the “Credit Facility”) to add the Company's German subsidiaries as European Borrowers (the "European Borrowers") and to provide for an additional $15 million European asset-based revolving credit facility subject to a European borrowing base (the "European Revolver"), increasing the facility limit under the ABL Facility to $55.0 million . On August 18, 2014, the Company entered into the Second Amendment to Credit and Guaranty Agreement (the “Second Amendment”). Under the Second Amendment, the Company borrowed an additional $30.0 million by utilizing the Incremental Facility. The $30.0 million in additional borrowings was used to finance a tax amnesty payment in Brazil. The Second Amendment made no changes to the repayment and other previously disclosed terms of the Credit Facility. The Credit Facility contains certain customary covenants that, subject to exceptions, restrict the Company's ability to, among other things: • declare dividends or redeem or repurchase equity interests; • prepay, redeem or purchase debt; • incur liens and engage in sale-leaseback transactions; • make loans and investments; • incur additional indebtedness; • amend or otherwise alter debt and other material agreements; • make capital expenditures in excess of $42 million per fiscal year, subject to adjustment; • engage in mergers, acquisitions and asset sales; • transact with affiliates; and • engage in businesses that are not related to the Company's existing business. On July 17, 2015 (the "Closing Date"), Xerium China, Co., Ltd. ("Xerium China"), a wholly-owned subsidiary of the Company entered into and closed a Fixed Assets Loan Contract (the "Loan Agreement") with the Industrial and Commercial Bank of China Limited, Shanghai-Jingan Branch (the “Bank”) with respect to a RMB 58.5 million loan, which was approximately $9.4 million USD on July 17, 2015. The loan is secured by pledged machinery and equipment of Xerium China and guaranteed by Xerium Asia Pacific (Shanghai) Limited and Stowe Woodward (Changzhou) Roll Technologies Co. Ltd., which are wholly-owned subsidiaries of the Company, pursuant to guarantee agreements (the "Guarantee Agreements"). Interest on the outstanding principal balance of the loan accrues at a benchmark rate plus a margin. The benchmark rate is the benchmark interest rate as published by the People's Bank of China, which was 5.25% on June 28, 2015. The margin is set at 10% of the benchmark rate for the entire loan period, with the current interest rate calculated at 5.78% . The interest rate will be adjusted every 12 months during the term of the loan, based on the benchmark interest rate adjustment. Interest under the loan is payable quarterly in arrears. Principal on the loan is to be repaid in part every six months following the Closing Date, in accordance with a predetermined schedule set forth in the Loan Agreement. Proceeds of the Loan will be used by Xerium China to purchase production equipment. The Loan Agreement contains certain customary representations and warranties and provisions relating to events of default. On November 3, 2015, the Company refinanced its existing ABL Facility and entered into a new Revolving Credit and Guaranty Agreement (as amended, the "New ABL Facility") with one of its existing ABL lenders, JPMorgan Chase Bank, N.A. Under the New ABL Facility, JPMorgan will become the lead domestic agent and will continue as the European agent. The amount of the ABL Facility will continue to provide aggregate availability of $55 million and the collateral pledged thereunder will also remain the same, however the New ABL Facility provides (1) increased flexibility for operations; (2) an extended maturity date of November, 2020; and (3) lower interest rates. As of September 30, 2015 , the outstanding balance of the Company's term debt under its Credit Facility and Notes was $460.9 million , which is net of a $0.7 million discount. In addition, as of September 30, 2015 , an aggregate of $33.0 million is available for additional borrowings. This availability represents a borrowing base of $44.6 million less $11.6 million of that facility committed for letters of credit or additional borrowings. As of September 30, 2015 and December 31, 2014, the carrying value of the Company’s debt was $484.3 million and $465.5 million , respectively, and its fair value was approximately $486.7 million and $478.2 million , respectively. The Company determined the fair value of its debt utilizing significant other observable inputs (Level 2 of the fair value hierarchy). Capitalized Lease Liabilities As of September 30, 2015 , the Company had capitalized lease liabilities totaling $5.1 million . These amounts represent the lease on the corporate headquarters and certain other software licensing, vehicle and office equipment capitalized lease arrangements.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company utilizes the liability method for accounting for income taxes in accordance with ASC Topic 740 , Income Taxes (“Topic 740”). Under Topic 740, deferred tax assets and liabilities are determined based on the difference between their financial reporting and tax basis. The assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company reduces its deferred tax assets by a valuation allowance if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In making this determination, the Company evaluates all available information including the Company’s financial position and results of operations for the current and preceding years, as well as any available projected information for future years. For the three and nine months ended September 30, 2015 , the provision for income taxes was $755 and $9,209 as compared to $29,218 and $33,440 for the three and nine months ended September 30, 2014 . The decrease in tax expense in the three months ended September 30, 2015, was primarily attributable to a $1,809 release of valuation allowance against Australian deferred tax assets along with decreased earnings in 2015, compared to a $25,298 tax provision recorded in 2014 related to settling a tax assessment in Brazil. The decrease in tax expense in the nine months ended September 30, 2015, was primarily attributable to a release of valuation allowance against Australian deferred tax assets partially offset by an increase in the unrecognized tax benefit due to the effects of income tax audits in 2015, compared to a tax provision recorded in 2014 related to settling a tax assessment in Brazil, along with the geographic mix of earnings. Generally, the provision for income taxes is primarily impacted by income earned in tax paying jurisdictions relative to income earned in non-tax paying jurisdictions. The majority of income recognized for purposes of computing the effective tax rate is earned in countries where the statutory income tax rates range from 15.0% to 35.6% ; however, permanent income adjustments recorded against pre-tax earnings may result in an effective tax rate that is higher or lower than the statutory tax rate in these jurisdictions. The Company generates losses in certain jurisdictions for which no tax benefit is realized, as the deferred tax assets in these jurisdictions (including the net operating losses) are fully reserved in the valuation allowance. For this reason, the Company recognizes minimal income tax expense or benefit in these jurisdictions, of which the most material jurisdictions are the United States and Australia. Due to these reserves, the geographic mix of the Company’s pre-tax earnings has a direct correlation with how high or low its annual effective tax rate is relative to consolidated earnings. As the Company continues to reorganize and restructure its operations, it is possible that deferred tax assets, for which no income tax benefit has previously been provided, may more likely than not become realized. During the quarter ended September 30, 2015, the Company reassessed its valuation allowance requirements related to its Australian operations, evaluating all available evidence in its analysis, both positive and negative, including historical and projected income and losses before the provision for income taxes, as well as reversals of temporary differences. The Company also considered tax planning strategies that are prudent and can be reasonably implemented if needed in order to realize the related tax benefits. During the third quarter of 2015, the Company recorded $1,809 of tax benefits related to the reversal of a portion of its valuation allowance previously established against its Australian net deferred tax assets. The Company believes that the deferred tax assets are more likely than not to be realized based on estimates of future taxable income generated by future earnings of the Australian business. The Company continues to evaluate future operations and will record an income tax benefit in the period where it believes it is more likely than not that the deferred tax asset will be able to be realized. Historic and future ownership changes could potentially reduce the amount of net operating loss carry-forwards available for use. As of September 30, 2015 , the Company had a gross amount of unrecognized tax benefit of $7,913 , exclusive of interest and penalties. The unrecognized tax benefit increased by approximately $412 during the nine months ended September 30, 2015 , as a result of ongoing changes in currently reserved positions as a result of new facts or information and the effects of income tax audits, which was partially offset by decreases related to foreign currency effects. In January 2015, the Company received notice of a tax audit report which could lead to an income tax assessment of an unknown amount related to its Italian operations. The Company expects to litigate if such an assessment is received, and the Company believes it would prevail on some portion of the issues litigated. As a result of this new information, the unrecognized tax benefit was increased by $1,269 for tax, interest and penalties related to this matter throughout 2015. The Company’s policy is to recognize interest and penalties related to income tax matters as income tax expense, which were $(89) and $806 related to the unrecognized tax benefits for the three and nine months ended September 30, 2015 . The tax years 2000 through 2014 remain open to examination in a number of the major tax jurisdictions to which the Company and its subsidiaries are subject. The Company believes that it has made adequate provisions for all income tax uncertainties.

Pensions, Other Post-retirement

Pensions, Other Post-retirement and Post-employment Benefits	9 Months Ended
	Sep. 30, 2015
Compensation and Retirement Disclosure [Abstract]
Pensions, Other Post-retirement and Post-employment Benefits	Pensions, Other Post-retirement and Post-employment Benefits The Company accounts for its pensions, other post-retirement and post-employment benefit plans in accordance with ASC Topic 715, Compensation—Retirement Benefits (“Topic 715”). The Company has defined benefit pension plans covering substantially all of its U.S. and Canadian employees and employees of certain subsidiaries in other countries. Benefits are generally based on the employee’s years of service and compensation. These plans are funded in conformity with the funding requirements of applicable government regulations. The Company does not fund certain plans, as funding is not required. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. In addition, the Company also intends to fund its U.K. and Canadian defined benefit plans in accordance with local regulations. As required by Topic 715, the following tables summarize the components of net periodic benefit cost: Defined Benefit Plans Curtailment accounting was triggered with the announced closure of the Warwick facility. As a result, a curtailment gain was recorded in the third quarter of 2015 in the amount of $2.9 million , as a reduction to pension liability, and an increase to other comprehensive loss. Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Service cost $ 765 $ 1,029 $ 2,155 $ 2,720 Interest cost 1,506 2,080 4,273 5,500 Expected return on plan assets (1,638 ) (1,972 ) (4,645 ) (5,213 ) Amortization of net loss 676 371 1,932 981 Net periodic benefit cost $ 1,309 $ 1,508 $ 3,715 $ 3,988

Comprehensive Loss and Accumula

Comprehensive Loss and Accumulated Other Comprehensive Loss	9 Months Ended
Comprehensive Loss and Accumulated Other Comprehensive Loss	Sep. 30, 2015
Equity [Abstract]
Comprehensive Loss and Accumulated Other Comprehensive Loss	Comprehensive Loss and Accumulated Other Comprehensive Loss Comprehensive loss for the three and nine months ended September 30, 2015 (net of tax expense of $97 and $183 , respectively) and 2014 (net of tax benefit of $(268) and $235 , respectively) is as follows: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Net income (loss) $ 915 $ (20,472 ) $ 1,945 $ (18,542 ) Foreign currency translation adjustments (14,333 ) (21,902 ) (40,701 ) (22,216 ) Pension liability changes under Topic 715 2,320 1,338 4,797 1,190 Change in value of derivative instruments 86 33 253 86 Comprehensive loss $ (11,012 ) $ (41,003 ) $ (33,706 ) $ (39,482 ) The components of accumulated other comprehensive loss for the three months ended September 30, 2015 are as follows (net of tax benefits of $7,970 ): Foreign Currency Translation Adjustment Pension Liability Changes Under Topic 715 Change in Value of Derivative Instruments Accumulated Other Comprehensive (Loss) Income Balance at June 30, 2015 $ (65,382 ) $ (44,339 ) $ 59 $ (109,662 ) Other comprehensive loss before reclassifications (14,333 ) (660 ) — (14,993 ) Amounts reclassified from other comprehensive loss Amortization of actuarial losses — 676 — 676 Pension curtailment — 2,304 — 2,304 Amortization of interest expense — — 86 86 Net current period other comprehensive loss (income) (14,333 ) 2,320 86 (11,927 ) Balance at September 30, 2015 $ (79,715 ) $ (42,019 ) $ 145 $ (121,589 ) The components of accumulated other comprehensive loss for the nine months ended September 30, 2015 are as follows (net of tax benefits of $7,970 ): Foreign Currency Translation Adjustment Pension Liability Changes Under Topic 715 Change in Value of Derivative Instruments Accumulated Other Comprehensive (Loss) Income Balance at December 31, 2014 $ (39,014 ) $ (46,816 ) $ (108 ) $ (85,938 ) Other comprehensive loss before reclassifications (40,701 ) 561 — (40,140 ) Amounts reclassified from other comprehensive loss Amortization of actuarial losses — 1,932 — 1,932 Pension curtailment — 2,304 — 2,304 Amortization of interest expense — — 253 253 Net current period other comprehensive (loss) income (40,701 ) 4,797 253 (35,651 ) Balance at September 30, 2015 $ (79,715 ) $ (42,019 ) $ 145 $ (121,589 ) For the three and nine months ended September 30, 2015 , the amortization of actuarial losses is included in cost of products sold and general and administrative expenses in the Consolidated Statements of Operations. For the nine months ended September 30, 2015 , the impact on Accumulated Other Comprehensive Loss ("AOCL") due to foreign currency translation adjustments of $(40,701) was primarily the result of the decline in the Euro and Brazilian Real and the effect of that decline on our foreign subsidiaries net equity balances of $151 million (Euro) and $107 million (Brazilian Real) in Europe and Brazil, respectively. The Euro declined to $1.12 at September 30, 2015 from $1.22 at December 31, 2014. The Brazilian Real declined to $0.25 at September 30, 2015 from $0.37 at December 31, 2014.

Restructuring and Impairment Ex

Restructuring and Impairment Expense	9 Months Ended
Restructuring and Impairment Expense	Sep. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring and Impairment Expense	Restructuring and Impairment Expense In October of 2015, the Company announced the permanent consolidation of its rolls manufacturing facility in Middletown, Virginia into other rolls manufacturing facilities. This closure will not affect the operations of the Company's global rolls R&D center in Middletown. It will give the R&D team more room to accomplish product development and prototypes on next generation products. The time-line to complete this process is by the end of March of 2016. The Company accrued $0.7 million in severance and asset relocation related charges in October of 2015 as a result of this consolidation. In June of 2015, the Company announced that it had initiated closure proceedings with the representative union officials at our machine clothing facility in Warwick, Quebec, Canada in order to continue to address our cost structure. In the second and third quarters of 2015, the Company incurred $3.5 million in employee-related and other restructuring expenses. In addition, we recognized $1.0 million in impairment charges related to the building during the third quarter of 2015 related to this closure. The building is classified as held for sale in the Company's Consolidated Condensed Balance Sheet at September 30, 2015 and currently has a carrying value of $0.5 million. The Company determined that this value falls within level 2 of the fair value hierarchy, based on sale price of comparable properties. For the nine months ended September 30, 2015 , the Company incurred restructuring expenses of $12.7 million. These included $4.1 million of charges related to the closure of the Joao Pessoa, Brazil clothing facility, $4.5 million charges related to the closure of Warwick, Canada machine clothing facility, as described above, and $4.1 million of charges relating to headcount reductions and other costs related to previous plant closures. For the nine months ended September 30, 2014, the Company incurred restructuring expenses of $15.7 million . These included charges relating to headcount reductions of $4.2 million , $3.0 million relating to the closure of the Joao Pessoa, Brazil plant, $1.6 million relating to the termination of a sales agency contract in Italy, $2.2 million relating to the closures of machine clothing facilities in Argentina and Spain, $3.7 million relating to the closure of the Heidenheim facility, $0.7 million relating to the transfer of certain machinery and equipment from the closed France rolls facility to a China based rolls facility and other locations in Europe, and $0.3 million relating to the liquidation of the Vietnam facility. The following table sets forth the significant components of the restructuring accrual (included in Accrued Expenses on our Consolidated Balance Sheet), including activity under restructuring programs for the nine months ended September 30, 2015 and 2014: Balance at Charges (1) Currency Cash Balance at Severance and other benefits $ 4,880 $ 6,007 $ (469 ) $ (4,744 ) $ 5,674 Facility costs and other 818 5,741 (76 ) (5,588 ) 895 Total $ 5,698 $ 11,748 $ (545 ) $ (10,332 ) $ 6,569 (1) Excludes $986 of impairment expense. Balance at Charges (1) Currency Cash Balance at Severance and other benefits $ 6,466 $ 11,737 $ (559 ) $ (11,884 ) $ 5,760 Facility costs and other 1,468 3,698 (176 ) (2,963 ) 2,027 Total $ 7,934 $ 15,435 $ (735 ) $ (14,847 ) $ 7,787 (1) Excludes $277 of impairment expense. Restructuring and impairment expense by segment, which is not included in Segment Earnings in Note 8, is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Clothing $ 4,414 $ 2,168 $ 11,516 $ 10,273 Roll Covers 540 1,272 827 5,310 Corporate 47 26 391 129 Total $ 5,001 $ 3,466 $ 12,734 $ 15,712

Business Segment Information

Business Segment Information	9 Months Ended
Business Segment Information	Sep. 30, 2015
Segment Reporting [Abstract]
Business Segment Information	Business Segment Information The Company is a global manufacturer and supplier of consumable products used primarily in the production of paper and is organized into two reportable segments: clothing and roll covers. The clothing segment represents the manufacture and sale of synthetic textile belts used to transport paper along the length of papermaking machines. The roll covers segment primarily represents the manufacture and refurbishment of covers used on the steel rolls of papermaking machines and the servicing of those rolls. The Company manages each of these operating segments separately. Management evaluates segment performance based on earnings before interest, taxes, depreciation and amortization, yet after allocation of corporate charges. Such measure is then adjusted to exclude items that are of an unusual nature and are not used in measuring segment performance or are not segment specific (“Segment Earnings (Loss)”). The accounting policies of these segments are the same as those for the Company as a whole. Inter-segment net sales and inter-segment eliminations are not material for any of the periods presented. Summarized financial information for the Company’s reportable segments is presented in the tables that follow for the three and nine months ended September 30, 2015 and 2014. Clothing Roll Corporate Total Three Months Ended September 30, 2015: Net Sales $ 72,536 $ 45,203 $ — $ 117,739 Segment Earnings (Loss) $ 22,230 $ 9,685 $ (3,654 ) Three Months Ended September 30, 2014: Net Sales $ 86,085 $ 52,773 $ — $ 138,858 Segment Earnings (Loss) $ 23,254 12,290 (4,080 ) Nine Months ended September 30, 2015: Net Sales $ 228,971 $ 132,925 $ — $ 361,896 Segment Earnings (Loss) $ 66,076 26,864 (10,467 ) Nine Months ended September 30, 2014: Net Sales $ 264,561 $ 147,404 $ — $ 411,965 Segment Earnings (Loss) $ 66,834 30,352 (10,600 ) Provided below is a reconciliation of Segment Earnings (Loss) to income before provision for income taxes for the three and nine months ended September 30, 2015 and 2014, respectively. Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Segment Earnings (Loss): Clothing $ 22,230 $ 23,254 $ 66,076 $ 66,834 Roll Covers 9,685 12,290 26,864 30,352 Corporate (3,654 ) (4,080 ) (10,467 ) (10,600 ) Stock-based compensation (1,064 ) (709 ) (2,690 ) (1,858 ) Inventory write-off related to closed facilities (465 ) — (465 ) — Idle equipment asset impairment (149 ) — (149 ) — Interest expense, net (9,775 ) (9,412 ) (28,144 ) (26,985 ) Depreciation and amortization (7,207 ) (8,594 ) (21,625 ) (26,180 ) Restructuring expense (5,001 ) (3,466 ) (12,734 ) (15,712 ) Non-recurring expense (1,552 ) — (2,402 ) — Plant startup costs (1,378 ) (537 ) (3,110 ) (953 ) Income before provision for income taxes $ 1,670 $ 8,746 $ 11,154 $ 14,898

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company is involved in various legal matters which have arisen in the ordinary course of business as a result of various immaterial labor claims, taxing authority reviews and other routine legal matters. As of September 30, 2015 , the Company accrued an immaterial amount in its financial statements for these matters for which the Company believed the possibility of loss was probable and was able to estimate the damages. The Company does not believe that the ultimate resolution of these matters will have a material adverse effect on its financial position, results of operations or cash flow. The Company believes that any additional liability in excess of amounts provided which may result from the resolution of legal matters will not have a material adverse effect on the financial condition, liquidity or cash flow of the Company.

Stock-Based Compensation and St

Stock-Based Compensation and Stockholders' Deficit	9 Months Ended
Stock-Based Compensation and Stockholders' Deficit	Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation and Stockholders' Deficit	Stock-Based Compensation and Stockholders’ Deficit The Company records stock-based compensation expense in accordance with ASC Topic 718, Accounting for Stock Compensation and has used the straight-line attribution method to recognize expense for RSUs, options and DSUs. The Company recorded stock-based compensation expense during the three and nine months ended September 30, 2015 and September 30, 2014 as follows: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 RSU, Options and DSU Awards (1) $ 1,064 $ 709 $ 2,690 $ 1,858 (1) Related to RSUs, Options and DSUs awarded to certain employees and non-employee directors. Summary of Activity under the Long-Term Incentive Plans On March 2, 2015, the Board of Directors approved the 2015-2017 Long-Term Incentive Plan (the “2015 - 2017 LTIP”) under the 2010 Equity Incentive Plan (the “2010 Plan”). Awards under the 2015 - 2017 LTIP are time-based, performance-based and market-based. A specific target share award has been set for each participant in the 2015-2017 LTIP. Awards will be paid in the form of shares of common stock of the Company, as described below: • 52,601 Time-based awards, or 35% of the total target award for each participant, have been granted in the form of time-based restricted stock units under the Company’s 2010 Plan. The time-based restricted stock units vest on the third anniversary of the date of grant. • 97,681 Performance-based and Market-based awards, 65% of the total target award for each participant, have been granted in the form of performance-based stock units under the 2010 Plan. Of these units, half will vest based on the financial performance of the Company and the other half will vest based on the stock price performance of the Company. The performance-based stock units whose vesting is subject to the financial performance of the Company (the “financial stock units”) will vest based on the degree to which the Company achieves a targeted three -year cumulative Adjusted EBITDA metric, adjusted for currency fluctuations, over the performance period of January 1, 2015 through December 31, 2017. Financial stock units that vest will convert into shares of the Company’s common stock and be paid after the close of a three -year performance period. The amount of units that vest will range from 0% to 100% of the employee's total financial stock units. Upon attainment of cumulative Adjusted EBITDA equal to 80% or less of the targeted Adjusted EBITDA, none of the financial stock units will vest. Upon attainment of more than 80% of the targeted Adjusted EBITDA, the financial stock units will begin vesting on a straight-line basis from 0% of the financial stock units at 80% of the targeted Adjusted EBITDA to 100% of the financial stock units at 100% of the targeted Adjusted EBITDA, up to a maximum payout of 100% of the financial stock units. The market-based stock units whose vesting is subject to stock price performance of the Company (the “market-based stock units”) will vest based on the Company's total stock price change (plus dividends) over the three -year performance period of March 2, 2015 through March 2, 2018 (“TSR”) relative to the TSR over the same performance period of companies listed on the S&P Global Small Cap Index on the third anniversary of the grant date, or March 2, 2018. Market-based stock units that vest will convert into shares of the Company’s common stock and will be paid after the third anniversary of the grant date, or March 2, 2018. The amount of units that vest will range from 0% to 100% of the employee's total market-based stock units. If the Company’s TSR over the performance period is less than the 35 th percentile TSR of companies in the S&P Global Small Cap Index, then no market-based units will vest. If the Company’s TSR over the performance period is equal to the 35th percentile TSR of the companies in the S&P Global Small Cap Index, then 50% of the market-based stock units will vest. Full payout at 100% of the market-based stock units will be made if the Company’s TSR over the performance period is equal to the 55th percentile TSR of companies in the S&P Global Small Cap Index. TSR performance between the 35th and 55th percentile TSR of companies in the S&P Global Small Cap Index will result in an interpolated payout percentage of the market-based stock units between 50% and 100% . Subject to early acceleration and payment under certain circumstances consistent with the terms of the Company’s 2015-2017 LTIP and LTIP Share Agreement thereunder, delivery of shares of common stock underlying the time-based and performance-based and market-based awards that become vested are subject to the participant’s continued service to the Company through March 2, 2018. Other Stock Compensation Plans On August 15, 2012, the Company granted Harold Bevis, the Company's CEO, an award of 204,208 restricted stock units and options to acquire 781,701 shares of the Company's common stock, par value $0.001 per share. Both the restricted stock units and the options vest over a three year period, with the first and second tranches having vested on August 15, 2014 and 2015. The options have a 10 -year term and an exercise price of $4.00 per share, the August 15, 2012 closing price of the Company's common stock on the New York Stock Exchange. On August 15, 2015, one third of Mr. Bevis's restricted stock units and options vested. Mr. Bevis received 35,596 shares of common stock, net of withholdings as a result of the restricted stock unit vesting. In addition, Mr. Bevis exercised his vested options, and received 99,632 shares of common stock, in a cashless exercise, net of withholdings. Directors’ Deferred Stock Unit Plan Under the 2011 non-management directors stock plan ("2011 DSU Plan”), as amended in January of 2015, each director receives an annual retainer of $132 , to be paid on a quarterly basis in arrears. Approximately half of the annual retainer is payable in DSUs, with the remaining half payable in DSUs, cash or a mix of both at the election of each director. The non-management directors were awarded an aggregate of 8,539 DSUs under the 2011 DSU Plan for service during the quarter ended September 30, 2015 . In addition, in accordance with the 2011 DSU Plan, as amended in January of 2015, 6,077 DSUs were settled in common stock during the quarter ended September 30, 2015 .

Supplemental Guarantor Financia

Supplemental Guarantor Financial Information	9 Months Ended
Supplemental Guarantor Financial Information	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Supplemental Guarantor Financial Information	Supplemental Guarantor Financial Information On May 26, 2011, the Company closed on the sale of its Notes. The Notes are unsecured obligations of the Company and are fully and unconditionally guaranteed on a senior unsecured basis by all of the domestic wholly owned subsidiaries of the Company (the “Guarantors”). In accordance with Rule 3-10 of Regulation S-X promulgated under the Securities Act of 1933, as amended, the following condensed consolidating financial statements present the financial position, results of operations and cash flows of Xerium Technologies, Inc. (referred to as “Parent” for the purpose of this note only) on a stand-alone parent-only basis, the Guarantors on a Guarantors-only basis, the combined non-Guarantor subsidiaries and elimination entries necessary to arrive at the information for the Parent, the Guarantors and non-Guarantor subsidiaries on a consolidated basis. Xerium Technologies, Inc. Consolidating Balance Sheet—(Unaudited) At September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The ASSETS Current assets: Cash and cash equivalents $ 3,710 $ (4 ) $ 6,998 $ — $ 10,704 Accounts receivable, net 120 22,492 55,201 — 77,813 Intercompany receivables (94,067 ) 114,766 (20,699 ) — — Inventories, net — 16,235 56,493 (925 ) 71,803 Prepaid expenses 1,246 1,564 5,465 — 8,275 Other current assets — 2,273 13,845 — 16,118 Total current assets (88,991 ) 157,326 117,303 (925 ) 184,713 Property and equipment, net 8,985 63,517 224,068 — 296,570 Investments 815,977 212,844 — (1,028,821 ) — Goodwill — 17,737 43,439 — 61,176 Intangible assets 6,877 1,457 792 — 9,126 Non-current deferred tax asset — — 9,555 — 9,555 Other assets — 364 8,734 — 9,098 Total assets $ 742,848 $ 453,245 $ 403,891 $ (1,029,746 ) $ 570,238 LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Current liabilities: Accounts payable $ 3,546 $ 10,732 $ 23,694 $ — $ 37,972 Accrued expenses 12,154 9,557 36,283 — 57,994 Notes payable — — 6,742 — 6,742 Current maturities of long-term debt 7,333 733 2,821 — 10,887 Total current liabilities 23,033 21,022 69,540 — 113,595 Long-term debt, net of current maturities 459,191 — 7,496 — 466,687 Liabilities under capital leases 3,337 761 969 — 5,067 Non-current deferred tax liability 758 1,035 6,098 — 7,891 Pension, other post-retirement and post-employment obligations 20,679 2,223 48,248 — 71,150 Other long-term liabilities — — 13,099 — 13,099 Intercompany loans 324,429 (399,025 ) 74,596 — — Total stockholders’ (deficit) equity (88,579 ) 827,229 183,845 (1,029,746 ) (107,251 ) Total liabilities and stockholders’ equity $ 742,848 $ 453,245 $ 403,891 $ (1,029,746 ) $ 570,238 Xerium Technologies, Inc. Consolidating Balance Sheet At December 31, 2014 (Dollars in thousands) Parent Total Total Non Other The ASSETS Current assets: Cash and cash equivalents $ 605 $ (14 ) $ 8,926 $ — $ 9,517 Accounts receivable, net 50 22,358 60,661 — 83,069 Intercompany receivables (107,064 ) 107,589 (525 ) — — Inventories, net — 17,310 67,016 (776 ) 83,550 Prepaid expenses 546 1,470 6,456 — 8,472 Other current assets — 2,021 13,693 — 15,714 Total current assets (105,863 ) 150,734 156,227 (776 ) 200,322 Property and equipment, net 12,365 59,448 231,804 — 303,617 Investments 782,633 229,109 — (1,011,742 ) — Goodwill — 17,737 44,190 — 61,927 Intangible assets 9,001 1,664 1,042 — 11,707 Non-current deferred tax asset — — 10,662 10,662 Other assets — 364 5,445 — 5,809 Total assets $ 698,136 $ 459,056 $ 449,370 $ (1,012,518 ) $ 594,044 LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Current liabilities: Accounts payable $ 2,679 $ 10,212 $ 28,936 $ — $ 41,827 Accrued expenses 8,511 8,301 39,297 — 56,109 Notes payable — — 244 — 244 Current maturities of long-term debt 2,944 — 1,462 — 4,406 Total current liabilities 14,134 18,513 69,939 — 102,586 Long-term debt, net of current maturities 460,840 — — — 460,840 Liabilities under capital leases 3,503 440 2 — 3,945 Non-current deferred tax liability 97 1,035 9,284 — 10,416 Pension, other post-retirement and post-employment obligations 22,070 1,200 57,201 — 80,471 Other long-term liabilities 181 — 9,715 — 9,896 Intercompany loans 289,896 (401,482 ) 111,586 — — Total stockholders’ (deficit) equity (92,585 ) 839,350 191,643 (1,012,518 ) (74,110 ) Total liabilities and stockholders’ (deficit) equity $ 698,136 $ 459,056 $ 449,370 $ (1,012,518 ) $ 594,044 Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited) For the three months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 41,978 $ 80,090 $ (4,329 ) $ 117,739 Costs and expenses: Cost of products sold 38 28,157 47,439 (4,382 ) 71,252 Selling 248 4,940 10,701 — 15,889 General and administrative 4,403 1,658 8,309 — 14,370 Research and development 259 1,118 464 — 1,841 Restructuring 47 307 4,647 — 5,001 4,995 36,180 71,560 (4,382 ) 108,353 (Loss) income from operations (4,995 ) 5,798 8,530 53 9,386 Interest (expense) income, net (9,613 ) 877 (1,039 ) — (9,775 ) Foreign exchange gain (loss) 404 (26 ) 1,681 — 2,059 Equity in subsidiaries income 10,415 9,460 — (19,875 ) — Dividend income 4,769 — — (4,769 ) — Income before provision for income taxes 980 16,109 9,172 (24,591 ) 1,670 Provision for income taxes (65 ) (19 ) (671 ) — (755 ) Net income $ 915 $ 16,090 $ 8,501 $ (24,591 ) $ 915 Comprehensive income (loss) $ 1,084 $ 16,391 $ (3,896 ) $ (24,591 ) $ (11,012 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income-(Unaudited) For the three months ended September 30, 2014 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 48,514 $ 98,675 $ (8,331 ) $ 138,858 Costs and expenses: Cost of products sold (225 ) 32,320 59,726 (8,457 ) 83,364 Selling 394 5,264 12,537 — 18,195 General and administrative 2,615 1,497 10,021 — 14,133 Research and development 244 1,189 476 — 1,909 Restructuring 26 123 3,317 — 3,466 3,054 40,393 86,077 (8,457 ) 121,067 (Loss) income from operations (3,054 ) 8,121 12,598 126 17,791 Interest (expense) income, net (8,842 ) 1,367 (1,937 ) — (9,412 ) Foreign exchange (loss) gain (346 ) (60 ) 773 — 367 Equity in subsidiaries (loss) income (7,787 ) (18,580 ) — 26,367 — (Loss) income before provision for income taxes (20,029 ) (9,152 ) 11,434 26,493 8,746 Provision for income taxes (443 ) (22 ) (28,753 ) — (29,218 ) Net loss $ (20,472 ) $ (9,174 ) $ (17,319 ) $ 26,493 $ (20,472 ) Comprehensive loss $ (21,626 ) $ (9,251 ) $ (36,619 ) $ 26,493 $ (41,003 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited) For the nine months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 126,416 $ 251,958 $ (16,478 ) $ 361,896 Costs and expenses: Cost of products sold (291 ) 85,079 148,954 (16,329 ) 217,413 Selling 787 14,790 33,068 — 48,645 General and administrative 9,285 4,539 26,437 — 40,261 Research and development 732 3,508 1,455 — 5,695 Restructuring 8,313 622 3,799 — 12,734 18,826 108,538 213,713 (16,329 ) 324,748 (Loss) income from operations (18,826 ) 17,878 38,245 (149 ) 37,148 Interest (expense) income, net (28,303 ) 3,009 (2,850 ) — (28,144 ) Foreign exchange gain (loss) 246 (261 ) 2,165 — 2,150 Equity in subsidiaries income 38,843 21,009 — (59,852 ) — Dividend income 10,856 — — (10,856 ) — Income before provision for income taxes 2,816 41,635 37,560 (70,857 ) 11,154 Provision for income taxes (871 ) (89 ) (8,249 ) — (9,209 ) Net income $ 1,945 $ 41,546 $ 29,311 $ (70,857 ) $ 1,945 Comprehensive income (loss) $ 3,439 $ 42,462 $ (8,750 ) $ (70,857 ) $ (33,706 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income-(Unaudited) For the nine months ended September 30, 2014 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 139,352 $ 299,501 $ (26,888 ) $ 411,965 Costs and expenses: Cost of products sold (1,095 ) 95,050 182,029 (27,030 ) 248,954 Selling 700 15,530 39,132 — 55,362 General and administrative 6,764 5,966 30,607 — 43,337 Research and development 779 3,453 1,667 — 5,899 Restructuring 129 868 14,715 — 15,712 7,277 120,867 268,150 (27,030 ) 369,264 (Loss) income from operations (7,277 ) 18,485 31,351 142 42,701 Interest (expense) income, net (25,546 ) 4,132 (5,571 ) — (26,985 ) Foreign exchange loss (549 ) (115 ) (154 ) — (818 ) Equity in subsidiaries income (loss) 15,558 (8,897 ) — (6,661 ) — (Loss) income before provision for income taxes (17,814 ) 13,605 25,626 (6,519 ) 14,898 Provision for income taxes (728 ) (100 ) (32,612 ) — (33,440 ) Net (loss) income $ (18,542 ) $ 13,505 $ (6,986 ) $ (6,519 ) $ (18,542 ) Comprehensive (loss) income $ (19,138 ) $ 13,087 $ (26,912 ) $ (6,519 ) $ (39,482 ) Xerium Technologies, Inc. Consolidating Statement of Cash Flows-(Unaudited) For the nine months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Operating activities Net income $ 1,945 $ 41,546 $ 29,311 $ (70,857 ) $ 1,945 Adjustments to reconcile net income to net cash (used in) provided by operating activities: Stock-based compensation 2,506 — 184 — 2,690 Depreciation 1,110 5,292 14,995 — 21,397 Amortization of intangibles — 206 22 — 228 Deferred financing cost amortization 2,570 — 71 — 2,641 Foreign exchange gain on revaluation of debt (2,115 ) — — — (2,115 ) Deferred taxes 661 — (2,232 ) — (1,571 ) Asset impairment — 149 1,029 — 1,178 Loss (gain) on disposition of property and equipment 4 27 (116 ) — (85 ) Provision for doubtful accounts — 276 581 — 857 Undistributed equity in earnings of subsidiaries (38,843 ) (21,009 ) — 59,852 — Change in assets and liabilities which provided (used) cash: Accounts receivable (70 ) (409 ) (2,310 ) — (2,789 ) Inventories — 1,074 2,417 149 3,640 Prepaid expenses (700 ) (94 ) 77 — (717 ) Other current assets — (252 ) (1,773 ) — (2,025 ) Accounts payable and accrued expenses 2,298 1,774 1,061 — 5,133 Deferred and other long-term liabilities (238 ) 1,023 (6,336 ) — (5,551 ) Intercompany loans (12,996 ) (7,108 ) 20,104 — — Net cash (used in) provided by operating activities (43,868 ) 22,495 57,085 (10,856 ) 24,856 Investing activities Capital expenditures (6,276 ) (7,862 ) (26,238 ) — (40,376 ) Intercompany property and equipment transfers, net 8,612 (220 ) (8,392 ) — — Proceeds from disposals of property and equipment 3 26 75 — 104 Net cash provided by (used in) investing activities 2,339 (8,056 ) (34,555 ) — (40,272 ) Financing activities — Net increase in notes payable — — 6,759 6,759 Proceeds from borrowings 37,408 — 20,020 — 57,428 Principal payments on debt (34,371 ) — (11,202 ) — (45,573 ) Dividends paid — (9,950 ) (906 ) 10,856 — Payment of obligations under capital leases (486 ) (401 ) — — (887 ) Payment of financing fees (63 ) — 45 — (18 ) Intercompany loans 36,646 (4,078 ) (32,568 ) — — Other financing activities 5,500 (5,500 ) — Net cash provided by (used in) financing activities 44,634 (14,429 ) (23,352 ) 10,856 17,709 Effect of exchange rate changes on cash flows — — (1,106 ) — (1,106 ) Net increase (decrease) in cash 3,105 10 (1,928 ) — 1,187 Cash and cash equivalents at beginning of period 605 (14 ) 8,926 — 9,517 Cash and cash equivalents at end of period $ 3,710 $ (4 ) $ 6,998 $ — $ 10,704 Xerium Technologies, Inc. Consolidating Statement of Cash Flows (Unaudited) For the nine months ended September 30, 2014 (Dollars in Thousands) Parent Total Total Non Other The Operating activities Net (loss) income $ (18,542 ) $ 13,505 $ (6,986 ) $ (6,519 ) $ (18,542 ) Adjustments to reconcile net (loss)income to net cash (used in) provided by operating activities: Stock-based compensation 1,673 — 185 — 1,858 Depreciation 809 5,415 18,726 — 24,950 Amortization of intangibles — 1,151 79 — 1,230 Deferred financing cost amortization 2,394 — 15 — 2,409 Foreign exchange gain on revaluation of debt (340 ) — — — (340 ) Deferred taxes 656 — 853 — 1,509 Asset impairment — — 277 — 277 Loss (gain) on disposition of property and equipment — 27 (31 ) — (4 ) Provision for doubtful accounts — 166 118 — 284 Undistributed equity in earnings of subsidiaries (15,558 ) 8,897 — 6,661 — Change in assets and liabilities which provided (used) cash: Accounts receivable (10 ) (705 ) (4,332 ) — (5,047 ) Inventories — 600 (8,355 ) (142 ) (7,897 ) Prepaid expenses 365 (802 ) 557 — 120 Other current assets 514 (517 ) 1,226 — 1,223 Accounts payable and accrued expenses 2,894 485 208 — 3,587 Deferred and other long-term liabilities (585 ) (39 ) (3,676 ) — (4,300 ) Intercompany loans (18,899 ) 553 18,346 — — Net cash (used in) provided by operating activities (44,629 ) 28,736 17,210 — 1,317 Investing activities Capital expenditures (10,229 ) (4,089 ) (19,348 ) — (33,666 ) Intercompany property and equipment transfers, net 13,204 (6 ) (13,198 ) — — Proceeds from disposals of property and equipment — 36 127 — 163 Other Investing Activities (26,100 ) 25,600 500 — — Net cash (used in) provided by investing activities (23,125 ) 21,541 (31,919 ) — (33,503 ) Financing activities — Proceeds from borrowings 67,943 — 5,636 — 73,579 Principal payments on debt (39,449 ) — (5,385 ) — (44,834 ) Payments of obligations under capitalized leases (383 ) (251 ) — — (634 ) Payment of deferred financing fees (623 ) — (775 ) — (1,398 ) Intercompany loans 37,885 (50,026 ) 12,141 — — Net cash provided by provided by (used in) financing activities 65,373 (50,277 ) 11,617 — 26,713 Effect of exchange rate changes on cash flows — 1 (431 ) — (430 ) Net (decrease) increase in cash (2,381 ) 1 (3,523 ) — (5,903 ) Cash and cash equivalents at beginning of period 4,120 (10 ) 21,606 — 25,716 Cash and cash equivalents at end of period $ 1,739 $ (9 ) $ 18,083 $ — $ 19,813

Description of Business and S17

Description of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated interim financial statements at September 30, 2015 and for the three and nine months ended September 30, 2015 and 2014 include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) for interim financial reporting and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Accordingly, such financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates. The interim results presented herein are not necessarily indicative of the results to be expected for the entire year. In management’s opinion, these unaudited condensed consolidated interim financial statements contain all adjustments of a normal recurring nature necessary for a fair presentation of the financial statements for the interim periods presented. These unaudited condensed consolidated interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2014 as reported on the Company's Annual Report on Form 10-K filed on March 4, 2015.
Inventories, net	Inventories, net Inventories are generally valued at the lower of cost or market using the first-in, first-out (FIFO) method. Raw materials are valued principally on a weighted average cost basis. The Company’s work in process and finished goods are specifically identified and valued based on actual inputs to production. Provisions are recorded as appropriate to write-down obsolete and excess inventory to estimated net realizable value. The process for evaluating obsolete and excess inventory often requires management to make subjective judgments and estimates concerning future sales levels, quantities and prices at which such inventory will be able to be sold in the normal course of business, while considering the general aging of inventory and factoring in any new business conditions.
Goodwill	Goodwill The Company accounts for goodwill and other intangible assets in accordance with ASC Topic 350, Intangibles—Goodwill and Other Intangible Assets (“Topic 350”). Topic 350 requires that goodwill and intangible assets that have indefinite lives not be amortized, but instead, must be tested for impairment at least annually or whenever events or business conditions warrant. During the nine months ended September 30, 2015 , the Company evaluated events and business conditions to determine if a test for an impairment of goodwill was warranted. No such events or business conditions took place during this period, therefore no test was determined to be warranted at September 30, 2015 .
Warranties	Warranties The Company offers warranties on certain roll products that it sells. The specific terms and conditions of these warranties vary depending on the product sold, the country in which the product is sold and arrangements with the customer. The Company estimates the costs that may be incurred under its warranties and records a liability in Accrued Expenses on its Consolidated Balance Sheet for such costs. Factors that affect the Company’s warranty liability include the number of units sold, historical and anticipated rates of warranty claims, cost per claim and new product introduction. The Company periodically assesses the adequacy of its recorded warranty claims and adjusts the amounts as necessary.
Net (Loss) Income Per Common Share	Net (Loss) Income Per Common Share Net (loss) income per common share has been computed and presented pursuant to the provisions of ASC Topic 260, Earnings per Share (“Topic 260”). Net (loss) income per share is based on the weighted-average number of shares outstanding during the period.
Impairment	Impairment The Company reviews its long-lived assets that have finite lives for impairment in accordance with ASC Topic 360, Property, Plant, and Equipment (“Topic 360”). This topic requires that companies evaluate the fair value of long-lived assets based on the anticipated undiscounted future cash flows to be generated by the assets when indicators of impairment exist to determine if there is impairment to the carrying value. Any change in the carrying amount of an asset as a result of the Company's evaluation has been recorded in either restructuring expense, if it was a result of the Company's restructuring activities, or general and administrative expense for all other impairments in the consolidated statements of operations.
New Accounting Pronouncements	New Accounting Pronouncements In May of 2014, the FASB issued Accounting Standard Update No. 2014-09 Revenue from Contracts with Customers ("ASU 2014-09"). ASU 2014-09 requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company identify the contract with the customer, identify the performance obligations in the contract, determine the transaction price, allocate the transaction price to the performance obligations in the contract and recognize revenue when it satisfies the performance obligations. The Company will also be required to disclose information regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. ASU 2014-09 is required to be adopted in January of 2018. Retrospective application is required either to all periods presented or with the cumulative effect of initial adoption recognized in the period of adoption. The Company is in the process of evaluating this accounting standard update. In April of 2015, the FASB issued Accounting Standard Update No. 2015-03 Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs ("ASU 2015-03"). ASU 2015-03 requires debt issuance costs related to a recognized debt liability be presented on the balance sheet as a direct deduction from the carrying value of the debt liability, consistent with debt discounts. ASU 2015-03 is required to be adopted in January of 2016. The Company will adopt this pronouncement at December 31, 2015, and believes that the adoption of ASU 2015-03 will not have a material impact on its consolidated financial statements.

Description of Business and S18

Description of Business and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Components of Inventories	The components of inventories are as follows at: September 30, December 31, Raw materials $ 12,383 $ 18,018 Work in process 26,055 28,756 Finished goods (includes consigned inventory of $6,985 at September 30, 2015 and $8,582 at December 31, 2014) 39,546 43,072 Inventory allowances (6,181 ) (6,296 ) $ 71,803 $ 83,550
Changes in Warranty Liability	The table below represents the changes in the Company’s warranty liability for the nine months ended September 30, 2015 and 2014: Beginning Balance Charged to Cost of Sales Effect of Foreign Currency Translation Deduction from Reserves Ending Balance Nine Months Ended September 30, 2015: $ 2,685 $ 1,184 $ (144 ) $ (1,580 ) $ 2,145 Nine Months Ended September 30, 2014: $ 1,629 $ 1,694 $ (86 ) $ (867 ) $ 2,370
Computation of Basic and Diluted Weighted-Average Shares	The following table sets forth the computation of basic and diluted weighted-average shares: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Weighted-average common shares outstanding–basic 15,667,103 15,475,836 15,595,793 15,426,125 Dilutive effect of stock-based compensation awards outstanding 899,967 — 844,732 — Weighted-average common shares outstanding–diluted 16,567,070 15,475,836 16,440,525 15,426,125
Schedule of Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share	The following table sets forth the aggregate of the dilutive securities that were outstanding in the three and nine months ended September 30, 2015 and 2014, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Anti-dilutive securities 24,002 1,313,627 20,237 1,313,627

Derivatives and Hedging (Tables

Derivatives and Hedging (Tables)	9 Months Ended
Derivatives and Hedging (Tables)	Sep. 30, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments	The following represents the fair value of these derivatives at September 30, 2015 and December 31, 2014 and the change in fair value included in foreign exchange gain in the three and nine months ended September 30, 2015 and 2014: September 30, 2015 December 31, 2014 Fair value of derivative asset (liability) $ 237 $ (524 ) Three Months Ended September 30, 2015: Three Months Ended September 30, 2014: Change in fair value of derivative included in foreign exchange loss $ (743 ) $ (123 ) Nine Months Ended September 30, 2015 Nine Months Ended September 30, 2014 Change in fair value of derivative included in foreign exchange loss $ (2,197 ) $ (1,328 )
Notional Amounts of Foreign Exchange Forward Contracts	The following represents the notional amounts of foreign exchange forward contracts at September 30, 2015 : Notional Sold Notional Purchased Non-designated hedges of foreign exchange risk $ 5,212 $ (38,814 )

Long-term Debt (Tables)

Long-term Debt (Tables)	9 Months Ended
Long-term Debt (Tables)	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Long Term Debt	At September 30, 2015 and December 31, 2014 , long term debt consisted of the following: September 30, 2015 December 31, 2014 Senior secured term loan facility, payable quarterly, U.S. Dollar denominated–LIBOR $ 224,475 $ 226,052 Senior Notes (Unsecured), payable semi-annually–U.S. Dollar denominated interest rate fixed at 8.875%. Matures June of 2018. 236,410 236,410 Notes payable, working capital loan, variable interest rate at 1.75%. Matures June 30, 2016, with one-year rollover option. 6,742 244 Fixed asset loan contract, variable interest rate of 5.78%. Matures June of 2020. 7,497 — Other debt 9,192 2,784 Total debt 484,316 465,490 Less current maturities of long term debt and notes payable 17,629 4,650 Total long term debt $ 466,687 $ 460,840

Pensions, Other Post-retireme21

Pensions, Other Post-retirement and Post-employment Benefits (Tables)	9 Months Ended
	Sep. 30, 2015
Compensation and Retirement Disclosure [Abstract]
Components of Net Periodic Benefit Cost	As required by Topic 715, the following tables summarize the components of net periodic benefit cost: Defined Benefit Plans Curtailment accounting was triggered with the announced closure of the Warwick facility. As a result, a curtailment gain was recorded in the third quarter of 2015 in the amount of $2.9 million , as a reduction to pension liability, and an increase to other comprehensive loss. Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Service cost $ 765 $ 1,029 $ 2,155 $ 2,720 Interest cost 1,506 2,080 4,273 5,500 Expected return on plan assets (1,638 ) (1,972 ) (4,645 ) (5,213 ) Amortization of net loss 676 371 1,932 981 Net periodic benefit cost $ 1,309 $ 1,508 $ 3,715 $ 3,988

Comprehensive Loss and Accumu22

Comprehensive Loss and Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2015
Equity [Abstract]
Components of Comprehensive Loss, Net of Tax	Comprehensive loss for the three and nine months ended September 30, 2015 (net of tax expense of $97 and $183 , respectively) and 2014 (net of tax benefit of $(268) and $235 , respectively) is as follows: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Net income (loss) $ 915 $ (20,472 ) $ 1,945 $ (18,542 ) Foreign currency translation adjustments (14,333 ) (21,902 ) (40,701 ) (22,216 ) Pension liability changes under Topic 715 2,320 1,338 4,797 1,190 Change in value of derivative instruments 86 33 253 86 Comprehensive loss $ (11,012 ) $ (41,003 ) $ (33,706 ) $ (39,482 )
Components of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss for the three months ended September 30, 2015 are as follows (net of tax benefits of $7,970 ): Foreign Currency Translation Adjustment Pension Liability Changes Under Topic 715 Change in Value of Derivative Instruments Accumulated Other Comprehensive (Loss) Income Balance at June 30, 2015 $ (65,382 ) $ (44,339 ) $ 59 $ (109,662 ) Other comprehensive loss before reclassifications (14,333 ) (660 ) — (14,993 ) Amounts reclassified from other comprehensive loss Amortization of actuarial losses — 676 — 676 Pension curtailment — 2,304 — 2,304 Amortization of interest expense — — 86 86 Net current period other comprehensive loss (income) (14,333 ) 2,320 86 (11,927 ) Balance at September 30, 2015 $ (79,715 ) $ (42,019 ) $ 145 $ (121,589 ) The components of accumulated other comprehensive loss for the nine months ended September 30, 2015 are as follows (net of tax benefits of $7,970 ): Foreign Currency Translation Adjustment Pension Liability Changes Under Topic 715 Change in Value of Derivative Instruments Accumulated Other Comprehensive (Loss) Income Balance at December 31, 2014 $ (39,014 ) $ (46,816 ) $ (108 ) $ (85,938 ) Other comprehensive loss before reclassifications (40,701 ) 561 — (40,140 ) Amounts reclassified from other comprehensive loss Amortization of actuarial losses — 1,932 — 1,932 Pension curtailment — 2,304 — 2,304 Amortization of interest expense — — 253 253 Net current period other comprehensive (loss) income (40,701 ) 4,797 253 (35,651 ) Balance at September 30, 2015 $ (79,715 ) $ (42,019 ) $ 145 $ (121,589 )

Restructuring and Impairment 23

Restructuring and Impairment Expense (Tables)	9 Months Ended
Restructuring and Impairment Expense (Tables)	Sep. 30, 2015
Restructuring and Related Activities [Abstract]
Restructuring Programs	The following table sets forth the significant components of the restructuring accrual (included in Accrued Expenses on our Consolidated Balance Sheet), including activity under restructuring programs for the nine months ended September 30, 2015 and 2014: Balance at Charges (1) Currency Cash Balance at Severance and other benefits $ 4,880 $ 6,007 $ (469 ) $ (4,744 ) $ 5,674 Facility costs and other 818 5,741 (76 ) (5,588 ) 895 Total $ 5,698 $ 11,748 $ (545 ) $ (10,332 ) $ 6,569 (1) Excludes $986 of impairment expense. Balance at Charges (1) Currency Cash Balance at Severance and other benefits $ 6,466 $ 11,737 $ (559 ) $ (11,884 ) $ 5,760 Facility costs and other 1,468 3,698 (176 ) (2,963 ) 2,027 Total $ 7,934 $ 15,435 $ (735 ) $ (14,847 ) $ 7,787 (1) Excludes $277 of impairment expense.
Restructuring and Impairment Expense by Segment	Restructuring and impairment expense by segment, which is not included in Segment Earnings in Note 8, is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2015 2014 2015 2014 Clothing $ 4,414 $ 2,168 $ 11,516 $ 10,273 Roll Covers 540 1,272 827 5,310 Corporate 47 26 391 129 Total $ 5,001 $ 3,466 $ 12,734 $ 15,712

Business Segment Information (T

Business Segment Information (Tables)	9 Months Ended
Business Segment Information (Tables)	Sep. 30, 2015
Segment Reporting [Abstract]
Summarized Financial Information and Segment Earnings (Loss)	Summarized financial information for the Company’s reportable segments is presented in the tables that follow for the three and nine months ended September 30, 2015 and 2014. Clothing Roll Corporate Total Three Months Ended September 30, 2015: Net Sales $ 72,536 $ 45,203 $ — $ 117,739 Segment Earnings (Loss) $ 22,230 $ 9,685 $ (3,654 ) Three Months Ended September 30, 2014: Net Sales $ 86,085 $ 52,773 $ — $ 138,858 Segment Earnings (Loss) $ 23,254 12,290 (4,080 ) Nine Months ended September 30, 2015: Net Sales $ 228,971 $ 132,925 $ — $ 361,896 Segment Earnings (Loss) $ 66,076 26,864 (10,467 ) Nine Months ended September 30, 2014: Net Sales $ 264,561 $ 147,404 $ — $ 411,965 Segment Earnings (Loss) $ 66,834 30,352 (10,600 ) Provided below is a reconciliation of Segment Earnings (Loss) to income before provision for income taxes for the three and nine months ended September 30, 2015 and 2014, respectively. Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 Segment Earnings (Loss): Clothing $ 22,230 $ 23,254 $ 66,076 $ 66,834 Roll Covers 9,685 12,290 26,864 30,352 Corporate (3,654 ) (4,080 ) (10,467 ) (10,600 ) Stock-based compensation (1,064 ) (709 ) (2,690 ) (1,858 ) Inventory write-off related to closed facilities (465 ) — (465 ) — Idle equipment asset impairment (149 ) — (149 ) — Interest expense, net (9,775 ) (9,412 ) (28,144 ) (26,985 ) Depreciation and amortization (7,207 ) (8,594 ) (21,625 ) (26,180 ) Restructuring expense (5,001 ) (3,466 ) (12,734 ) (15,712 ) Non-recurring expense (1,552 ) — (2,402 ) — Plant startup costs (1,378 ) (537 ) (3,110 ) (953 ) Income before provision for income taxes $ 1,670 $ 8,746 $ 11,154 $ 14,898

Stock-Based Compensation and 25

Stock-Based Compensation and Stockholders' Deficit (Tables)	9 Months Ended
Stock-Based Compensation and Stockholders' Deficit (Tables)	Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation Expense	The Company recorded stock-based compensation expense during the three and nine months ended September 30, 2015 and September 30, 2014 as follows: Three Months ended September 30, Nine Months ended September 30, 2015 2014 2015 2014 RSU, Options and DSU Awards (1) $ 1,064 $ 709 $ 2,690 $ 1,858 (1) Related to RSUs, Options and DSUs awarded to certain employees and non-employee directors.

Supplemental Guarantor Financ26

Supplemental Guarantor Financial Information (Tables)	9 Months Ended
Supplemental Guarantor Financial Information (Tables)	Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidating Balance Sheet (Unaudited)	Xerium Technologies, Inc. Consolidating Balance Sheet—(Unaudited) At September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The ASSETS Current assets: Cash and cash equivalents $ 3,710 $ (4 ) $ 6,998 $ — $ 10,704 Accounts receivable, net 120 22,492 55,201 — 77,813 Intercompany receivables (94,067 ) 114,766 (20,699 ) — — Inventories, net — 16,235 56,493 (925 ) 71,803 Prepaid expenses 1,246 1,564 5,465 — 8,275 Other current assets — 2,273 13,845 — 16,118 Total current assets (88,991 ) 157,326 117,303 (925 ) 184,713 Property and equipment, net 8,985 63,517 224,068 — 296,570 Investments 815,977 212,844 — (1,028,821 ) — Goodwill — 17,737 43,439 — 61,176 Intangible assets 6,877 1,457 792 — 9,126 Non-current deferred tax asset — — 9,555 — 9,555 Other assets — 364 8,734 — 9,098 Total assets $ 742,848 $ 453,245 $ 403,891 $ (1,029,746 ) $ 570,238 LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Current liabilities: Accounts payable $ 3,546 $ 10,732 $ 23,694 $ — $ 37,972 Accrued expenses 12,154 9,557 36,283 — 57,994 Notes payable — — 6,742 — 6,742 Current maturities of long-term debt 7,333 733 2,821 — 10,887 Total current liabilities 23,033 21,022 69,540 — 113,595 Long-term debt, net of current maturities 459,191 — 7,496 — 466,687 Liabilities under capital leases 3,337 761 969 — 5,067 Non-current deferred tax liability 758 1,035 6,098 — 7,891 Pension, other post-retirement and post-employment obligations 20,679 2,223 48,248 — 71,150 Other long-term liabilities — — 13,099 — 13,099 Intercompany loans 324,429 (399,025 ) 74,596 — — Total stockholders’ (deficit) equity (88,579 ) 827,229 183,845 (1,029,746 ) (107,251 ) Total liabilities and stockholders’ equity $ 742,848 $ 453,245 $ 403,891 $ (1,029,746 ) $ 570,238 Xerium Technologies, Inc. Consolidating Balance Sheet At December 31, 2014 (Dollars in thousands) Parent Total Total Non Other The ASSETS Current assets: Cash and cash equivalents $ 605 $ (14 ) $ 8,926 $ — $ 9,517 Accounts receivable, net 50 22,358 60,661 — 83,069 Intercompany receivables (107,064 ) 107,589 (525 ) — — Inventories, net — 17,310 67,016 (776 ) 83,550 Prepaid expenses 546 1,470 6,456 — 8,472 Other current assets — 2,021 13,693 — 15,714 Total current assets (105,863 ) 150,734 156,227 (776 ) 200,322 Property and equipment, net 12,365 59,448 231,804 — 303,617 Investments 782,633 229,109 — (1,011,742 ) — Goodwill — 17,737 44,190 — 61,927 Intangible assets 9,001 1,664 1,042 — 11,707 Non-current deferred tax asset — — 10,662 10,662 Other assets — 364 5,445 — 5,809 Total assets $ 698,136 $ 459,056 $ 449,370 $ (1,012,518 ) $ 594,044 LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY Current liabilities: Accounts payable $ 2,679 $ 10,212 $ 28,936 $ — $ 41,827 Accrued expenses 8,511 8,301 39,297 — 56,109 Notes payable — — 244 — 244 Current maturities of long-term debt 2,944 — 1,462 — 4,406 Total current liabilities 14,134 18,513 69,939 — 102,586 Long-term debt, net of current maturities 460,840 — — — 460,840 Liabilities under capital leases 3,503 440 2 — 3,945 Non-current deferred tax liability 97 1,035 9,284 — 10,416 Pension, other post-retirement and post-employment obligations 22,070 1,200 57,201 — 80,471 Other long-term liabilities 181 — 9,715 — 9,896 Intercompany loans 289,896 (401,482 ) 111,586 — — Total stockholders’ (deficit) equity (92,585 ) 839,350 191,643 (1,012,518 ) (74,110 ) Total liabilities and stockholders’ (deficit) equity $ 698,136 $ 459,056 $ 449,370 $ (1,012,518 ) $ 594,044
Consolidating Statement of Operations and Comprehensive (Loss) Income (Unaudited)	Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited) For the three months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 41,978 $ 80,090 $ (4,329 ) $ 117,739 Costs and expenses: Cost of products sold 38 28,157 47,439 (4,382 ) 71,252 Selling 248 4,940 10,701 — 15,889 General and administrative 4,403 1,658 8,309 — 14,370 Research and development 259 1,118 464 — 1,841 Restructuring 47 307 4,647 — 5,001 4,995 36,180 71,560 (4,382 ) 108,353 (Loss) income from operations (4,995 ) 5,798 8,530 53 9,386 Interest (expense) income, net (9,613 ) 877 (1,039 ) — (9,775 ) Foreign exchange gain (loss) 404 (26 ) 1,681 — 2,059 Equity in subsidiaries income 10,415 9,460 — (19,875 ) — Dividend income 4,769 — — (4,769 ) — Income before provision for income taxes 980 16,109 9,172 (24,591 ) 1,670 Provision for income taxes (65 ) (19 ) (671 ) — (755 ) Net income $ 915 $ 16,090 $ 8,501 $ (24,591 ) $ 915 Comprehensive income (loss) $ 1,084 $ 16,391 $ (3,896 ) $ (24,591 ) $ (11,012 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income-(Unaudited) For the three months ended September 30, 2014 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 48,514 $ 98,675 $ (8,331 ) $ 138,858 Costs and expenses: Cost of products sold (225 ) 32,320 59,726 (8,457 ) 83,364 Selling 394 5,264 12,537 — 18,195 General and administrative 2,615 1,497 10,021 — 14,133 Research and development 244 1,189 476 — 1,909 Restructuring 26 123 3,317 — 3,466 3,054 40,393 86,077 (8,457 ) 121,067 (Loss) income from operations (3,054 ) 8,121 12,598 126 17,791 Interest (expense) income, net (8,842 ) 1,367 (1,937 ) — (9,412 ) Foreign exchange (loss) gain (346 ) (60 ) 773 — 367 Equity in subsidiaries (loss) income (7,787 ) (18,580 ) — 26,367 — (Loss) income before provision for income taxes (20,029 ) (9,152 ) 11,434 26,493 8,746 Provision for income taxes (443 ) (22 ) (28,753 ) — (29,218 ) Net loss $ (20,472 ) $ (9,174 ) $ (17,319 ) $ 26,493 $ (20,472 ) Comprehensive loss $ (21,626 ) $ (9,251 ) $ (36,619 ) $ 26,493 $ (41,003 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income (Loss) (Unaudited) For the nine months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 126,416 $ 251,958 $ (16,478 ) $ 361,896 Costs and expenses: Cost of products sold (291 ) 85,079 148,954 (16,329 ) 217,413 Selling 787 14,790 33,068 — 48,645 General and administrative 9,285 4,539 26,437 — 40,261 Research and development 732 3,508 1,455 — 5,695 Restructuring 8,313 622 3,799 — 12,734 18,826 108,538 213,713 (16,329 ) 324,748 (Loss) income from operations (18,826 ) 17,878 38,245 (149 ) 37,148 Interest (expense) income, net (28,303 ) 3,009 (2,850 ) — (28,144 ) Foreign exchange gain (loss) 246 (261 ) 2,165 — 2,150 Equity in subsidiaries income 38,843 21,009 — (59,852 ) — Dividend income 10,856 — — (10,856 ) — Income before provision for income taxes 2,816 41,635 37,560 (70,857 ) 11,154 Provision for income taxes (871 ) (89 ) (8,249 ) — (9,209 ) Net income $ 1,945 $ 41,546 $ 29,311 $ (70,857 ) $ 1,945 Comprehensive income (loss) $ 3,439 $ 42,462 $ (8,750 ) $ (70,857 ) $ (33,706 ) Xerium Technologies, Inc. Consolidating Statement of Operations and Comprehensive Income-(Unaudited) For the nine months ended September 30, 2014 (Dollars in thousands) Parent Total Total Non Other The Net sales $ — $ 139,352 $ 299,501 $ (26,888 ) $ 411,965 Costs and expenses: Cost of products sold (1,095 ) 95,050 182,029 (27,030 ) 248,954 Selling 700 15,530 39,132 — 55,362 General and administrative 6,764 5,966 30,607 — 43,337 Research and development 779 3,453 1,667 — 5,899 Restructuring 129 868 14,715 — 15,712 7,277 120,867 268,150 (27,030 ) 369,264 (Loss) income from operations (7,277 ) 18,485 31,351 142 42,701 Interest (expense) income, net (25,546 ) 4,132 (5,571 ) — (26,985 ) Foreign exchange loss (549 ) (115 ) (154 ) — (818 ) Equity in subsidiaries income (loss) 15,558 (8,897 ) — (6,661 ) — (Loss) income before provision for income taxes (17,814 ) 13,605 25,626 (6,519 ) 14,898 Provision for income taxes (728 ) (100 ) (32,612 ) — (33,440 ) Net (loss) income $ (18,542 ) $ 13,505 $ (6,986 ) $ (6,519 ) $ (18,542 ) Comprehensive (loss) income $ (19,138 ) $ 13,087 $ (26,912 ) $ (6,519 ) $ (39,482 )
Consolidating Statement of Cash Flows (Unaudited)	Xerium Technologies, Inc. Consolidating Statement of Cash Flows-(Unaudited) For the nine months ended September 30, 2015 (Dollars in thousands) Parent Total Total Non Other The Operating activities Net income $ 1,945 $ 41,546 $ 29,311 $ (70,857 ) $ 1,945 Adjustments to reconcile net income to net cash (used in) provided by operating activities: Stock-based compensation 2,506 — 184 — 2,690 Depreciation 1,110 5,292 14,995 — 21,397 Amortization of intangibles — 206 22 — 228 Deferred financing cost amortization 2,570 — 71 — 2,641 Foreign exchange gain on revaluation of debt (2,115 ) — — — (2,115 ) Deferred taxes 661 — (2,232 ) — (1,571 ) Asset impairment — 149 1,029 — 1,178 Loss (gain) on disposition of property and equipment 4 27 (116 ) — (85 ) Provision for doubtful accounts — 276 581 — 857 Undistributed equity in earnings of subsidiaries (38,843 ) (21,009 ) — 59,852 — Change in assets and liabilities which provided (used) cash: Accounts receivable (70 ) (409 ) (2,310 ) — (2,789 ) Inventories — 1,074 2,417 149 3,640 Prepaid expenses (700 ) (94 ) 77 — (717 ) Other current assets — (252 ) (1,773 ) — (2,025 ) Accounts payable and accrued expenses 2,298 1,774 1,061 — 5,133 Deferred and other long-term liabilities (238 ) 1,023 (6,336 ) — (5,551 ) Intercompany loans (12,996 ) (7,108 ) 20,104 — — Net cash (used in) provided by operating activities (43,868 ) 22,495 57,085 (10,856 ) 24,856 Investing activities Capital expenditures (6,276 ) (7,862 ) (26,238 ) — (40,376 ) Intercompany property and equipment transfers, net 8,612 (220 ) (8,392 ) — — Proceeds from disposals of property and equipment 3 26 75 — 104 Net cash provided by (used in) investing activities 2,339 (8,056 ) (34,555 ) — (40,272 ) Financing activities — Net increase in notes payable — — 6,759 6,759 Proceeds from borrowings 37,408 — 20,020 — 57,428 Principal payments on debt (34,371 ) — (11,202 ) — (45,573 ) Dividends paid — (9,950 ) (906 ) 10,856 — Payment of obligations under capital leases (486 ) (401 ) — — (887 ) Payment of financing fees (63 ) — 45 — (18 ) Intercompany loans 36,646 (4,078 ) (32,568 ) — — Other financing activities 5,500 (5,500 ) — Net cash provided by (used in) financing activities 44,634 (14,429 ) (23,352 ) 10,856 17,709 Effect of exchange rate changes on cash flows — — (1,106 ) — (1,106 ) Net increase (decrease) in cash 3,105 10 (1,928 ) — 1,187 Cash and cash equivalents at beginning of period 605 (14 ) 8,926 — 9,517 Cash and cash equivalents at end of period $ 3,710 $ (4 ) $ 6,998 $ — $ 10,704 Xerium Technologies, Inc. Consolidating Statement of Cash Flows (Unaudited) For the nine months ended September 30, 2014 (Dollars in Thousands) Parent Total Total Non Other The Operating activities Net (loss) income $ (18,542 ) $ 13,505 $ (6,986 ) $ (6,519 ) $ (18,542 ) Adjustments to reconcile net (loss)income to net cash (used in) provided by operating activities: Stock-based compensation 1,673 — 185 — 1,858 Depreciation 809 5,415 18,726 — 24,950 Amortization of intangibles — 1,151 79 — 1,230 Deferred financing cost amortization 2,394 — 15 — 2,409 Foreign exchange gain on revaluation of debt (340 ) — — — (340 ) Deferred taxes 656 — 853 — 1,509 Asset impairment — — 277 — 277 Loss (gain) on disposition of property and equipment — 27 (31 ) — (4 ) Provision for doubtful accounts — 166 118 — 284 Undistributed equity in earnings of subsidiaries (15,558 ) 8,897 — 6,661 — Change in assets and liabilities which provided (used) cash: Accounts receivable (10 ) (705 ) (4,332 ) — (5,047 ) Inventories — 600 (8,355 ) (142 ) (7,897 ) Prepaid expenses 365 (802 ) 557 — 120 Other current assets 514 (517 ) 1,226 — 1,223 Accounts payable and accrued expenses 2,894 485 208 — 3,587 Deferred and other long-term liabilities (585 ) (39 ) (3,676 ) — (4,300 ) Intercompany loans (18,899 ) 553 18,346 — — Net cash (used in) provided by operating activities (44,629 ) 28,736 17,210 — 1,317 Investing activities Capital expenditures (10,229 ) (4,089 ) (19,348 ) — (33,666 ) Intercompany property and equipment transfers, net 13,204 (6 ) (13,198 ) — — Proceeds from disposals of property and equipment — 36 127 — 163 Other Investing Activities (26,100 ) 25,600 500 — — Net cash (used in) provided by investing activities (23,125 ) 21,541 (31,919 ) — (33,503 ) Financing activities — Proceeds from borrowings 67,943 — 5,636 — 73,579 Principal payments on debt (39,449 ) — (5,385 ) — (44,834 ) Payments of obligations under capitalized leases (383 ) (251 ) — — (634 ) Payment of deferred financing fees (623 ) — (775 ) — (1,398 ) Intercompany loans 37,885 (50,026 ) 12,141 — — Net cash provided by provided by (used in) financing activities 65,373 (50,277 ) 11,617 — 26,713 Effect of exchange rate changes on cash flows — 1 (431 ) — (430 ) Net (decrease) increase in cash (2,381 ) 1 (3,523 ) — (5,903 ) Cash and cash equivalents at beginning of period 4,120 (10 ) 21,606 — 25,716 Cash and cash equivalents at end of period $ 1,739 $ (9 ) $ 18,083 $ — $ 19,813

Description of Business and S27

Description of Business and Significant Accounting Policies - Components of Inventories (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 12,383	$ 18,018
Work in process	26,055	28,756
Finished goods (includes consigned inventory of $6,985 at September 30, 2015 and $8,582 at December 31, 2014)	39,546	43,072
Inventory allowances	(6,181)	(6,296)
Inventories, net	71,803	83,550
Consigned inventory	$ 6,985	$ 8,582

Description of Business and S28

Description of Business and Significant Accounting Policies - Changes In Warranty Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Warranties, Increase (Decrease)
Beginning Balance	$ 2,685	$ 1,629
Charged to Cost of Sales	1,184	1,694
Effect of Foreign Currency Translation	(144)	(86)
Deduction from Reserves	(1,580)	(867)
Ending Balance	$ 2,145	$ 2,370

Description of Business and S29

Description of Business and Significant Accounting Policies - Net (Loss) Income (Loss) Per Common Share (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Weighted-average common shares outstanding–basic (in shares)	15,667,103	15,475,836	15,595,793	15,426,125
Dilutive effect of stock-based compensation awards outstanding (in shares)	899,967	0	844,732	0
Weighted-average common shares outstanding–diluted (in shares)	16,567,070	15,475,836	16,440,525	15,426,125
Anti-dilutive securities (in shares)	24,002	1,313,627	20,237	1,313,627

Description of Business and S30

Description of Business and Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Restructuring Expense
Restructuring Cost and Reserve [Line Items]
Asset impairment	$ 1	$ 0.3

Derivatives and Hedging - Narra

Derivatives and Hedging - Narrative (Details)	Sep. 30, 2015derivative_instrument
Designated as Hedging Instrument \| Interest Rate Swap
Derivative [Line Items]
Number of derivative instruments	0

Derivatives and Hedging - Sched

Derivatives and Hedging - Schedule of Derivative Instruments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Derivative [Line Items]
Change in fair value of derivative included in foreign exchange loss	$ (743)	$ (123)	$ (2,197)	$ (1,328)
Not Designated as Hedging Instrument \| Foreign Exchange Forward Contracts
Derivative [Line Items]
Fair value of derivative asset (liability)	$ 237		$ 237		$ (524)

Derivatives and Hedging - Notio

Derivatives and Hedging - Notional Amounts of Foreign Exchange Forward Contracts (Detail) - Not Designated as Hedging Instrument - Foreign Exchange Forward Contracts $ in Thousands	Sep. 30, 2015USD ($)
Sold
Derivative [Line Items]
Non-designated hedges of foreign exchange risk	$ 5,212
Purchased
Derivative [Line Items]
Non-designated hedges of foreign exchange risk	$ (38,814)

Long term Debt - Schedule of Lo

Long term Debt - Schedule of Long Term Debt (Detail) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014	May. 17, 2013
Debt Instrument [Line Items]
Long-term debt	$ 484,300	$ 465,500
Notes payable	6,742	244
Total debt	484,316	465,490
Less current maturities of long term debt and notes payable	17,629	4,650
Total long term debt	466,687	460,840
Other Debt
Debt Instrument [Line Items]
Long-term debt	9,192	2,784
Notes Payable
Debt Instrument [Line Items]
Notes payable	$ 6,742	244
Debt instrument variable interest rate	1.75%
Rollover option period	1 year
Senior Secured Term Loan Facility \| Senior Secured Term Loan Facility, Payable Quarterly, US Dollar Denominated, Matures May 2019
Debt Instrument [Line Items]
Long-term debt	$ 224,475	$ 226,052
Debt instrument interest rate	6.25%	6.25%
Debt discount	$ 700	$ 700	$ 1,000
Senior Secured Term Loan Facility \| Senior Secured Term Loan Facility, Payable Quarterly, US Dollar Denominated, Matures May 2019 \| London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt Instrument, minimum variable rate basis	1.25%	1.25%
Debt instrument, basis spread on variable rate	5.00%	5.00%
Senior Notes (Unsecured) \| Senior Notes Unsecured, Payable Semi Annually, US Dollar Denominated Interest Rate Fixed at 8.875%, Matures June 2018
Debt Instrument [Line Items]
Long-term debt	$ 236,410	$ 236,410
Debt instrument fixed interest rate	8.875%	8.875%
Capital Lease Obligations \| Fixed Asset Loan Contract
Debt Instrument [Line Items]
Fixed asset loan	$ 7,497	$ 0
Debt instrument interest rate	5.78%	5.78%

Long term Debt - Additional Inf

Long term Debt - Additional Information (Detail)	Jul. 17, 2015USD ($)	Jun. 28, 2015	Aug. 18, 2014USD ($)	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Nov. 02, 2015USD ($)	Jul. 17, 2015CNY (¥)	Dec. 31, 2014USD ($)	Mar. 03, 2014USD ($)	May. 17, 2013USD ($)
Debt Instrument [Line Items]
Proceeds from borrowings				$ 57,428,000	$ 73,579,000
Carrying value of long-term debt				484,300,000				$ 465,500,000
Fair value of long-term debt				486,700,000				478,200,000
Liabilities under capital leases				5,067,000				3,945,000
Credit Facility and Notes
Debt Instrument [Line Items]
Debt discount				700,000
Carrying value of long-term debt				460,900,000
Senior Secured Term Loan Facility, Payable Quarterly, US Dollar Denominated, Matures May 2019 \| Secured Debt
Debt Instrument [Line Items]
Debt instrument, face amount										$ 200,000,000
Debt discount				700,000				700,000		1,000,000
Proceeds from borrowings			$ 30,000,000
Carrying value of long-term debt				224,475,000				$ 226,052,000
ABL Secured Facility \| Revolving Credit Facility
Debt Instrument [Line Items]
Current borrowing capacity									$ 55,000,000	$ 40,000,000
Debt instrument, covenant compliance, maximum annual capital expenditures (in excess of)				42,000,000
Remaining borrowing capacity				33,000,000
Amount outstanding				44,600,000
ABL Secured Facility \| Letter of Credit
Debt Instrument [Line Items]
Amount outstanding				$ 11,600,000
ABL Secured Facility - European \| Revolving Credit Facility
Debt Instrument [Line Items]
Current borrowing capacity									$ 15,000,000
Xerium China Loan Agreement \| Secured Debt
Debt Instrument [Line Items]
Debt instrument, face amount	$ 9,400,000						¥ 58,500,000
Interest rate adjustment period	12 months
Frequency of principal payment	6 months
Brazil \| Foreign Tax Authority \| Senior Secured Term Loan Facility, Payable Quarterly, US Dollar Denominated, Matures May 2019 \| Secured Debt
Debt Instrument [Line Items]
Proceeds from borrowings			$ 30,000,000
Benchmark Rate \| Xerium China Loan Agreement \| Secured Debt
Debt Instrument [Line Items]
Debt instrument, variable rate		5.25%
Debt instrument, percentage of variable rate used to calculate basis spread		10.00%
Interest rate during period		5.78%
Subsequent Event
Debt Instrument [Line Items]
Current borrowing capacity						$ 55,000,000

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Income Taxes [Line Items]
Provision for income taxes	$ (755)	$ (29,218)	$ (9,209)	$ (33,440)
Deferred tax assets, valuation allowance	1,809
Effective income tax rate reconciliation, tax settlement, foreign, amount					$ 25,298
Gross unrecognized tax benefit	7,913		7,913
Increase in unrecognized tax benefits			412
Unrecognized tax benefit increase resulting from potential settlement			1,269
Unrecognized tax benefits related to income tax matters and income tax expense	(89)		$ 806
Minimum
Income Taxes [Line Items]
Statutory income tax rate in foreign countries			15.00%
Maximum
Income Taxes [Line Items]
Statutory income tax rate in foreign countries			35.60%
Australia
Income Taxes [Line Items]
Provision for income taxes	$ 1,809

Pensions, Other Post-retireme37

Pensions, Other Post-retirement and Post-employment Benefits - Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]
Curtailment gain	$ 2,900
Pensions, Other Post-Retirement And Post-Employment Benefits [Abstract]
Service cost	765	$ 1,029	$ 2,155	$ 2,720
Interest cost	1,506	2,080	4,273	5,500
Expected return on plan assets	(1,638)	(1,972)	(4,645)	(5,213)
Amortization of net loss	676	371	1,932	981
Net periodic benefit cost	$ 1,309	$ 1,508	$ 3,715	$ 3,988

Comprehensive Loss and Accumu38

Comprehensive Loss and Accumulated Other Comprehensive Loss - Components of Comprehensive Loss, Net of Tax (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Comprehensive Income Loss and Accumulated Other Comprehensive Income (Loss) [Abstract]
Other comprehensive loss, tax (benefit) expense	$ 97	$ (268)	$ 183	$ 235
Net income (loss)	915	(20,472)	1,945	(18,542)
Foreign currency translation adjustments	(14,333)	(21,902)	(40,701)	(22,216)
Pension liability changes under Topic 715	2,320	1,338	4,797	1,190
Change in value of derivative instruments	86	33	253	86
Comprehensive loss	$ (11,012)	$ (41,003)	$ (33,706)	$ (39,482)

Comprehensive Loss and Accumu39

Comprehensive Loss and Accumulated Other Comprehensive Loss - Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2015
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at beginning	$ (109,662)	$ (85,938)
Other comprehensive loss before reclassifications	(14,993)	(40,140)
Amounts reclassified from other comprehensive loss
Amortization of actuarial losses	676	1,932
Pension curtailment	2,304	2,304
Amortization of interest expense	86	253
Net current period other comprehensive (loss) income	(11,927)	(35,651)
Balance at end	(121,589)	(121,589)
Accumulated other comprehensive loss, tax benefit	7,970	7,970
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at beginning	(65,382)	(39,014)
Other comprehensive loss before reclassifications	(14,333)	(40,701)
Amounts reclassified from other comprehensive loss
Amortization of actuarial losses	0	0
Amortization of interest expense	0	0
Net current period other comprehensive (loss) income	(14,333)	(40,701)
Balance at end	(79,715)	(79,715)
Pension Liability Changes Under Topic 715
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at beginning	(44,339)	(46,816)
Other comprehensive loss before reclassifications	(660)	561
Amounts reclassified from other comprehensive loss
Amortization of actuarial losses	676	1,932
Pension curtailment	2,304	2,304
Amortization of interest expense	0	0
Net current period other comprehensive (loss) income	2,320	4,797
Balance at end	(42,019)	(42,019)
Change in Value of Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance at beginning	59	(108)
Other comprehensive loss before reclassifications	0	0
Amounts reclassified from other comprehensive loss
Amortization of actuarial losses	0	0
Amortization of interest expense	86	253
Net current period other comprehensive (loss) income	86	253
Balance at end	$ 145	$ 145

Comprehensive Loss and Accumu40

Comprehensive Loss and Accumulated Other Comprehensive Loss - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)	Dec. 31, 2014USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive loss, foreign currency translation adjustment	$ (40,701)
Net equity of foreign subsidiary	(107,251)	$ (74,110)
Europe
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net equity of foreign subsidiary	151,000
Brazil
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net equity of foreign subsidiary	$ 107,000
Euro
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency exchange rate	1.12	1.22
Brazil Real
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign currency exchange rate	0.25	0.37

Restructuring and Impairment 41

Restructuring and Impairment Expense - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Oct. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Restructuring Cost and Reserve [Line Items]
Severance costs	$ 6,569	$ 7,787	$ 6,569	$ 7,787		$ 5,698	$ 7,934
Charges (1)			11,748	15,435
Restructuring	5,001	3,466	12,734	15,712
Headcount Reductions
Restructuring Cost and Reserve [Line Items]
Severance costs	5,674	$ 5,760	5,674	5,760		$ 4,880	$ 6,466
Charges (1)			6,007	11,737
Restructuring			4,100	4,200
Italy Facility \| Termination of Contract
Restructuring Cost and Reserve [Line Items]
Restructuring				1,600
Veitnam Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring				300
Clothing Facility \| Brazil Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring			4,100	3,000
Clothing Facility \| Canada Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Asset impairment	$ 1,000
Restructuring			4,500
Clothing Facility \| Canada Facility \| Headcount Reductions
Restructuring Cost and Reserve [Line Items]
Charges (1)			$ 3,500
Clothing Facility \| Argentina and Spain Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring				2,200
Rolls Facility \| Heidenheim Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring				3,700
Rolls Facility \| France Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring				$ 700
Subsequent Event \| Rolls facility \| Middleton Facility \| Facility Closing
Restructuring Cost and Reserve [Line Items]
Severance costs					$ 700

Restructuring and Impairment 42

Restructuring and Impairment Expense - Restructuring Programs (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Restructuring Cost and Reserve [Line Items]
Impairment expense	$ 986	$ 277
Restructuring Reserve
Beginning Balance	5,698	7,934
Charges (1)	11,748	15,435
Currency Effects	(545)	(735)
Cash Payments	(10,332)	(14,847)
Ending Balance	6,569	7,787
Severance and other benefits
Restructuring Reserve
Beginning Balance	4,880	6,466
Charges (1)	6,007	11,737
Currency Effects	(469)	(559)
Cash Payments	(4,744)	(11,884)
Ending Balance	5,674	5,760
Facility costs and other
Restructuring Reserve
Beginning Balance	818	1,468
Charges (1)	5,741	3,698
Currency Effects	(76)	(176)
Cash Payments	(5,588)	(2,963)
Ending Balance	$ 895	$ 2,027

Restructuring and Impairment 43

Restructuring and Impairment Expense - Restructuring and Impairment Expense by Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 5,001	$ 3,466	$ 12,734	$ 15,712
Operating Segments \| Clothing
Restructuring Cost and Reserve [Line Items]
Restructuring	4,414	2,168	11,516	10,273
Operating Segments \| Roll Covers
Restructuring Cost and Reserve [Line Items]
Restructuring	540	1,272	827	5,310
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 47	$ 26	$ 391	$ 129

Business Segment Information -

Business Segment Information - Additional Information (Details)	9 Months Ended
	Sep. 30, 2015segment
Segment Reporting [Abstract]
Number of reportable segments	2

Business Segment Information 45

Business Segment Information - Summarized Financial Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Segment Reporting Information [Line Items]
Net Sales	$ 117,739	$ 138,858	$ 361,896	$ 411,965
Segment Earnings (Loss)	9,386	17,791	37,148	42,701
Operating Segments \| Clothing
Segment Reporting Information [Line Items]
Net Sales	72,536	86,085	228,971	264,561
Segment Earnings (Loss)	22,230	23,254	66,076	66,834
Operating Segments \| Roll Covers
Segment Reporting Information [Line Items]
Net Sales	45,203	52,773	132,925	147,404
Segment Earnings (Loss)	9,685	12,290	26,864	30,352
Corporate
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
Segment Earnings (Loss)	$ (3,654)	$ (4,080)	$ (10,467)	$ (10,600)

Business Segment Information 46

Business Segment Information - Reconciliation of Segment Earnings (Loss) To Income Before Provision For Income Taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Segment Earnings (Loss):
Segment Earnings (Loss)	$ 9,386	$ 17,791	$ 37,148	$ 42,701
Stock-based compensation	(1,064)	(709)	(2,690)	(1,858)
Inventory write-off related to closed facilities	(465)	0	(465)	0
Idle equipment asset impairment	(149)	0	(149)	0
Interest expense, net	(9,775)	(9,412)	(28,144)	(26,985)
Depreciation and amortization	(7,207)	(8,594)	(21,625)	(26,180)
Restructuring expense	(5,001)	(3,466)	(12,734)	(15,712)
Non-recurring expense	(1,552)	0	(2,402)	0
Plant startup costs	(1,378)	(537)	(3,110)	(953)
Income before provision for income taxes	1,670	8,746	11,154	14,898
Operating Segments \| Clothing
Segment Earnings (Loss):
Segment Earnings (Loss)	22,230	23,254	66,076	66,834
Restructuring expense	(4,414)	(2,168)	(11,516)	(10,273)
Operating Segments \| Roll Covers
Segment Earnings (Loss):
Segment Earnings (Loss)	9,685	12,290	26,864	30,352
Restructuring expense	(540)	(1,272)	(827)	(5,310)
Corporate
Segment Earnings (Loss):
Segment Earnings (Loss)	(3,654)	(4,080)	(10,467)	(10,600)
Restructuring expense	$ (47)	$ (26)	$ (391)	$ (129)

Stock-Based Compensation and 47

Stock-Based Compensation and Stockholders' Deficit - Stock-Based Compensation Expense (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense		$ 1,064	$ 709	$ 2,690	$ 1,858
RSU, Options and DSU Awards
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	[1]	$ 1,064	$ 709	$ 2,690	$ 1,858

[1]	Related to RSUs, Options and DSUs awarded to certain employees and non-employee directors.

Stock-Based Compensation and 48

Stock-Based Compensation and Stockholders' Deficit - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Aug. 15, 2015	Mar. 02, 2015	Aug. 15, 2012	Aug. 12, 2012	Sep. 30, 2015	Sep. 30, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock par value					$ 0.001	$ 0.001	$ 0.001
2011 DSU Plan \| Deferred Stock Unit (DSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Annual retainer per director						$ 132
Shares issued					8,539,000
Percentage of retainer payable in shares						50.00%
Percentage of retainer payable in shares and/or cash						50.00%
2015 - 2017 LTIP \| Time-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized		52,601,000
Percent of target award		35.00%
Award vesting period		3 years
2015 - 2017 LTIP \| Performance-Based and Market-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized		97,681,000
Percent of target award		65.00%
2015 - 2017 LTIP \| Performance-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Performance measurement period		3 years
2015 - 2017 LTIP \| Performance-Based Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		0.00%
2015 - 2017 LTIP \| Performance-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		100.00%
Percentage of award payout		100.00%
2015 - 2017 LTIP \| Market-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Performance measurement period		3 years
2015 - 2017 LTIP \| Market-Based Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		0.00%
2015 - 2017 LTIP \| Market-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		100.00%
Tranche One \| 2015 - 2017 LTIP \| Performance-Based and Market-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		50.00%
Tranche One \| 2015 - 2017 LTIP \| Performance-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		0.00%
Tranche One \| 2015 - 2017 LTIP \| Performance-Based Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		80.00%
Tranche One \| 2015 - 2017 LTIP \| Performance-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		80.00%
Tranche One \| 2015 - 2017 LTIP \| Market-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		0.00%
Tranche One \| 2015 - 2017 LTIP \| Market-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		35.00%
Tranche Two \| 2015 - 2017 LTIP \| Performance-Based and Market-Based Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		50.00%
Tranche Two \| 2015 - 2017 LTIP \| Performance-Based Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		0.00%
Performance threshold percentage		80.00%
Tranche Two \| 2015 - 2017 LTIP \| Performance-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		100.00%
Performance threshold percentage		100.00%
Tranche Two \| 2015 - 2017 LTIP \| Market-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting, percentage		50.00%
Performance threshold percentage		35.00%
Tranche Three \| 2015 - 2017 LTIP \| Market-Based Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		55.00%
Percentage of award payout		100.00%
Tranche Three \| 2015 - 2017 LTIP \| Market-Based Stock Units \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		35.00%
Percentage of award payout		50.00%
Tranche Three \| 2015 - 2017 LTIP \| Market-Based Stock Units \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance threshold percentage		55.00%
Percentage of award payout		100.00%
Common Stock \| 2011 DSU Plan \| Deferred Stock Unit (DSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued					6,077,000
Chief Executive Officer \| Chief Executive Officer Stock Compensation Plan \| Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				3 years
Award vesting, percentage	33.33%
Restricted stock units granted to CEO			204,208
Options contract term				10 years
Options exercise price				$ 4
Common stock issued to CEO	35,596
Chief Executive Officer \| Chief Executive Officer Stock Compensation Plan \| Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period				3 years
Award vesting, percentage	33.33%
Shares authorized for issuance			781,701
Stock options exercised by CEO	99,632

Supplemental Guarantor Financ49

Supplemental Guarantor Financial Information - Consolidating Balance Sheet (Unaudited) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 10,704	$ 9,517	$ 19,813	$ 25,716
Accounts receivable, net	77,813	83,069
Intercompany receivables	0	0
Inventories, net	71,803	83,550
Prepaid expenses	8,275	8,472
Other current assets	16,118	15,714
Total current assets	184,713	200,322
Property and equipment, net	296,570	303,617
Investments	0	0
Goodwill	61,176	61,927
Intangible assets	9,126	11,707
Non-current deferred tax asset	9,555	10,662
Other assets	9,098	5,809
Total assets	570,238	594,044
Current liabilities:
Accounts payable	37,972	41,827
Accrued expenses	57,994	56,109
Notes payable	6,742	244
Current maturities of long-term debt	10,887	4,406
Total current liabilities	113,595	102,586
Long-term debt, net of current maturities	466,687	460,840
Liabilities under capital leases	5,067	3,945
Non-current deferred tax liability	7,891	10,416
Pension, other post-retirement and post-employment obligations	71,150	80,471
Other long-term liabilities	13,099	9,896
Intercompany loans	0	0
Total stockholders’ (deficit) equity	(107,251)	(74,110)
Total liabilities and stockholders’ deficit	570,238	594,044
Parent
Current assets:
Cash and cash equivalents	3,710	605	1,739	4,120
Accounts receivable, net	120	50
Intercompany receivables	(94,067)	(107,064)
Inventories, net	0	0
Prepaid expenses	1,246	546
Other current assets	0	0
Total current assets	(88,991)	(105,863)
Property and equipment, net	8,985	12,365
Investments	815,977	782,633
Goodwill	0	0
Intangible assets	6,877	9,001
Non-current deferred tax asset	0	0
Other assets	0	0
Total assets	742,848	698,136
Current liabilities:
Accounts payable	3,546	2,679
Accrued expenses	12,154	8,511
Notes payable	0	0
Current maturities of long-term debt	7,333	2,944
Total current liabilities	23,033	14,134
Long-term debt, net of current maturities	459,191	460,840
Liabilities under capital leases	3,337	3,503
Non-current deferred tax liability	758	97
Pension, other post-retirement and post-employment obligations	20,679	22,070
Other long-term liabilities	0	181
Intercompany loans	324,429	289,896
Total stockholders’ (deficit) equity	(88,579)	(92,585)
Total liabilities and stockholders’ deficit	742,848	698,136
Total Guarantors
Current assets:
Cash and cash equivalents	(4)	(14)	(9)	(10)
Accounts receivable, net	22,492	22,358
Intercompany receivables	114,766	107,589
Inventories, net	16,235	17,310
Prepaid expenses	1,564	1,470
Other current assets	2,273	2,021
Total current assets	157,326	150,734
Property and equipment, net	63,517	59,448
Investments	212,844	229,109
Goodwill	17,737	17,737
Intangible assets	1,457	1,664
Non-current deferred tax asset	0	0
Other assets	364	364
Total assets	453,245	459,056
Current liabilities:
Accounts payable	10,732	10,212
Accrued expenses	9,557	8,301
Notes payable	0	0
Current maturities of long-term debt	733	0
Total current liabilities	21,022	18,513
Long-term debt, net of current maturities	0	0
Liabilities under capital leases	761	440
Non-current deferred tax liability	1,035	1,035
Pension, other post-retirement and post-employment obligations	2,223	1,200
Other long-term liabilities	0	0
Intercompany loans	(399,025)	(401,482)
Total stockholders’ (deficit) equity	827,229	839,350
Total liabilities and stockholders’ deficit	453,245	459,056
Total Non Guarantors
Current assets:
Cash and cash equivalents	6,998	8,926	18,083	21,606
Accounts receivable, net	55,201	60,661
Intercompany receivables	(20,699)	(525)
Inventories, net	56,493	67,016
Prepaid expenses	5,465	6,456
Other current assets	13,845	13,693
Total current assets	117,303	156,227
Property and equipment, net	224,068	231,804
Investments	0	0
Goodwill	43,439	44,190
Intangible assets	792	1,042
Non-current deferred tax asset	9,555	10,662
Other assets	8,734	5,445
Total assets	403,891	449,370
Current liabilities:
Accounts payable	23,694	28,936
Accrued expenses	36,283	39,297
Notes payable	6,742	244
Current maturities of long-term debt	2,821	1,462
Total current liabilities	69,540	69,939
Long-term debt, net of current maturities	7,496	0
Liabilities under capital leases	969	2
Non-current deferred tax liability	6,098	9,284
Pension, other post-retirement and post-employment obligations	48,248	57,201
Other long-term liabilities	13,099	9,715
Intercompany loans	74,596	111,586
Total stockholders’ (deficit) equity	183,845	191,643
Total liabilities and stockholders’ deficit	403,891	449,370
Other Eliminations
Current assets:
Cash and cash equivalents	0	0	$ 0	$ 0
Accounts receivable, net	0	0
Intercompany receivables	0	0
Inventories, net	(925)	(776)
Prepaid expenses	0	0
Other current assets	0	0
Total current assets	(925)	(776)
Property and equipment, net	0	0
Investments	(1,028,821)	(1,011,742)
Goodwill	0	0
Intangible assets	0	0
Non-current deferred tax asset	0
Other assets	0	0
Total assets	(1,029,746)	(1,012,518)
Current liabilities:
Accounts payable	0	0
Accrued expenses	0	0
Notes payable	0	0
Current maturities of long-term debt	0	0
Total current liabilities	0	0
Long-term debt, net of current maturities	0	0
Liabilities under capital leases	0	0
Non-current deferred tax liability	0	0
Pension, other post-retirement and post-employment obligations	0	0
Other long-term liabilities	0	0
Intercompany loans	0	0
Total stockholders’ (deficit) equity	(1,029,746)	(1,012,518)
Total liabilities and stockholders’ deficit	$ (1,029,746)	$ (1,012,518)

Supplemental Guarantor Financ50

Supplemental Guarantor Financial Information - Consolidating Statement of Operations and Comprehensive (Loss) Income (Unaudited) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Condensed Income Statements, Captions [Line Items]
Net Sales	$ 117,739	$ 138,858	$ 361,896	$ 411,965
Costs and expenses:
Cost of products sold	71,252	83,364	217,413	248,954
Selling	15,889	18,195	48,645	55,362
General and administrative	14,370	14,133	40,261	43,337
Research and development	1,841	1,909	5,695	5,899
Restructuring	5,001	3,466	12,734	15,712
Costs and expenses	108,353	121,067	324,748	369,264
Income from operations	9,386	17,791	37,148	42,701
Interest (expense) income, net	(9,775)	(9,412)	(28,144)	(26,985)
Foreign exchange gain (loss)	2,059	367	2,150	(818)
Equity in subsidiaries income	0	0	0	0
Dividend income	0		0
Income before provision for income taxes	1,670	8,746	11,154	14,898
Provision for income taxes	(755)	(29,218)	(9,209)	(33,440)
Net income (loss)	915	(20,472)	1,945	(18,542)
Comprehensive loss	(11,012)	(41,003)	(33,706)	(39,482)
Parent
Condensed Income Statements, Captions [Line Items]
Net Sales	0	0	0	0
Costs and expenses:
Cost of products sold	38	(225)	(291)	(1,095)
Selling	248	394	787	700
General and administrative	4,403	2,615	9,285	6,764
Research and development	259	244	732	779
Restructuring	47	26	8,313	129
Costs and expenses	4,995	3,054	18,826	7,277
Income from operations	(4,995)	(3,054)	(18,826)	(7,277)
Interest (expense) income, net	(9,613)	(8,842)	(28,303)	(25,546)
Foreign exchange gain (loss)	404	(346)	246	(549)
Equity in subsidiaries income	10,415	(7,787)	38,843	15,558
Dividend income	4,769		10,856
Income before provision for income taxes	980	(20,029)	2,816	(17,814)
Provision for income taxes	(65)	(443)	(871)	(728)
Net income (loss)	915	(20,472)	1,945	(18,542)
Comprehensive loss	1,084	(21,626)	3,439	(19,138)
Total Guarantors
Condensed Income Statements, Captions [Line Items]
Net Sales	41,978	48,514	126,416	139,352
Costs and expenses:
Cost of products sold	28,157	32,320	85,079	95,050
Selling	4,940	5,264	14,790	15,530
General and administrative	1,658	1,497	4,539	5,966
Research and development	1,118	1,189	3,508	3,453
Restructuring	307	123	622	868
Costs and expenses	36,180	40,393	108,538	120,867
Income from operations	5,798	8,121	17,878	18,485
Interest (expense) income, net	877	1,367	3,009	4,132
Foreign exchange gain (loss)	(26)	(60)	(261)	(115)
Equity in subsidiaries income	9,460	(18,580)	21,009	(8,897)
Dividend income	0		0
Income before provision for income taxes	16,109	(9,152)	41,635	13,605
Provision for income taxes	(19)	(22)	(89)	(100)
Net income (loss)	16,090	(9,174)	41,546	13,505
Comprehensive loss	16,391	(9,251)	42,462	13,087
Total Non Guarantors
Condensed Income Statements, Captions [Line Items]
Net Sales	80,090	98,675	251,958	299,501
Costs and expenses:
Cost of products sold	47,439	59,726	148,954	182,029
Selling	10,701	12,537	33,068	39,132
General and administrative	8,309	10,021	26,437	30,607
Research and development	464	476	1,455	1,667
Restructuring	4,647	3,317	3,799	14,715
Costs and expenses	71,560	86,077	213,713	268,150
Income from operations	8,530	12,598	38,245	31,351
Interest (expense) income, net	(1,039)	(1,937)	(2,850)	(5,571)
Foreign exchange gain (loss)	1,681	773	2,165	(154)
Equity in subsidiaries income	0	0	0	0
Dividend income	0		0
Income before provision for income taxes	9,172	11,434	37,560	25,626
Provision for income taxes	(671)	(28,753)	(8,249)	(32,612)
Net income (loss)	8,501	(17,319)	29,311	(6,986)
Comprehensive loss	(3,896)	(36,619)	(8,750)	(26,912)
Other Eliminations
Condensed Income Statements, Captions [Line Items]
Net Sales	(4,329)	(8,331)	(16,478)	(26,888)
Costs and expenses:
Cost of products sold	(4,382)	(8,457)	(16,329)	(27,030)
Selling	0	0	0	0
General and administrative	0	0	0	0
Research and development	0	0	0	0
Restructuring	0	0	0	0
Costs and expenses	(4,382)	(8,457)	(16,329)	(27,030)
Income from operations	53	126	(149)	142
Interest (expense) income, net	0	0	0	0
Foreign exchange gain (loss)	0	0	0	0
Equity in subsidiaries income	(19,875)	26,367	(59,852)	(6,661)
Dividend income	(4,769)		(10,856)
Income before provision for income taxes	(24,591)	26,493	(70,857)	(6,519)
Provision for income taxes	0	0	0	0
Net income (loss)	(24,591)	26,493	(70,857)	(6,519)
Comprehensive loss	$ (24,591)	$ 26,493	$ (70,857)	$ (6,519)

Supplemental Guarantor Financ51

Supplemental Guarantor Financial Information - Consolidating Statement of Cash Flows (Unaudited) (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating activities
Net income (loss)	$ 915	$ (20,472)	$ 1,945	$ (18,542)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Stock-based compensation			2,690	1,858
Depreciation			21,397	24,950
Amortization of intangibles			228	1,230
Deferred financing cost amortization			2,641	2,409
Foreign exchange gain on revaluation of debt			(2,115)	(340)
Deferred taxes			(1,571)	1,509
Asset impairment			1,178	277
Gain on disposition of property and equipment			(85)	(4)
Provision for doubtful accounts			857	284
Undistributed equity in earnings of subsidiaries			0	0
Change in assets and liabilities which provided (used) cash:
Accounts receivable			(2,789)	(5,047)
Inventories			3,640	(7,897)
Prepaid expenses			(717)	120
Other current assets			(2,025)	1,223
Accounts payable and accrued expenses			5,133	3,587
Deferred and other long-term liabilities			(5,551)	(4,300)
Intercompany loans			0	0
Net cash provided by operating activities			24,856	1,317
Investing activities
Capital expenditures			(40,376)	(33,666)
Intercompany property and equipment transfers, net			0	0
Proceeds from disposals of property and equipment			104	163
Other Investing Activities				0
Net cash used in investing activities			(40,272)	(33,503)
Financing activities
Net increase in notes payable			6,759
Proceeds from borrowings			57,428	73,579
Principal payments on debt			(45,573)	(44,834)
Dividends paid			0
Payment of obligations under capital leases			(887)	(634)
Payment of financing fees			(18)	(1,398)
Intercompany loans			0	0
Other financing activities			0
Net cash provided by financing activities			17,709	26,713
Effect of exchange rate changes on cash flows			(1,106)	(430)
Net increase (decrease) in cash			1,187	(5,903)
Cash and cash equivalents at beginning of period			9,517	25,716
Cash and cash equivalents at end of period	10,704	19,813	10,704	19,813
Parent
Operating activities
Net income (loss)	915	(20,472)	1,945	(18,542)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Stock-based compensation			2,506	1,673
Depreciation			1,110	809
Amortization of intangibles			0	0
Deferred financing cost amortization			2,570	2,394
Foreign exchange gain on revaluation of debt			(2,115)	(340)
Deferred taxes			661	656
Asset impairment			0	0
Gain on disposition of property and equipment			4	0
Provision for doubtful accounts			0	0
Undistributed equity in earnings of subsidiaries			(38,843)	(15,558)
Change in assets and liabilities which provided (used) cash:
Accounts receivable			(70)	(10)
Inventories			0	0
Prepaid expenses			(700)	365
Other current assets			0	514
Accounts payable and accrued expenses			2,298	2,894
Deferred and other long-term liabilities			(238)	(585)
Intercompany loans			(12,996)	(18,899)
Net cash provided by operating activities			(43,868)	(44,629)
Investing activities
Capital expenditures			(6,276)	(10,229)
Intercompany property and equipment transfers, net			8,612	13,204
Proceeds from disposals of property and equipment			3	0
Other Investing Activities				(26,100)
Net cash used in investing activities			2,339	(23,125)
Financing activities
Net increase in notes payable			0
Proceeds from borrowings			37,408	67,943
Principal payments on debt			(34,371)	(39,449)
Dividends paid			0
Payment of obligations under capital leases			(486)	(383)
Payment of financing fees			(63)	(623)
Intercompany loans			36,646	37,885
Other financing activities			5,500
Net cash provided by financing activities			44,634	65,373
Effect of exchange rate changes on cash flows			0	0
Net increase (decrease) in cash			3,105	(2,381)
Cash and cash equivalents at beginning of period			605	4,120
Cash and cash equivalents at end of period	3,710	1,739	3,710	1,739
Total Guarantors
Operating activities
Net income (loss)	16,090	(9,174)	41,546	13,505
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Stock-based compensation			0	0
Depreciation			5,292	5,415
Amortization of intangibles			206	1,151
Deferred financing cost amortization			0	0
Foreign exchange gain on revaluation of debt			0	0
Deferred taxes			0	0
Asset impairment			149	0
Gain on disposition of property and equipment			27	27
Provision for doubtful accounts			276	166
Undistributed equity in earnings of subsidiaries			(21,009)	8,897
Change in assets and liabilities which provided (used) cash:
Accounts receivable			(409)	(705)
Inventories			1,074	600
Prepaid expenses			(94)	(802)
Other current assets			(252)	(517)
Accounts payable and accrued expenses			1,774	485
Deferred and other long-term liabilities			1,023	(39)
Intercompany loans			(7,108)	553
Net cash provided by operating activities			22,495	28,736
Investing activities
Capital expenditures			(7,862)	(4,089)
Intercompany property and equipment transfers, net			(220)	(6)
Proceeds from disposals of property and equipment			26	36
Other Investing Activities				25,600
Net cash used in investing activities			(8,056)	21,541
Financing activities
Net increase in notes payable			0
Proceeds from borrowings			0	0
Principal payments on debt			0	0
Dividends paid			(9,950)
Payment of obligations under capital leases			(401)	(251)
Payment of financing fees			0	0
Intercompany loans			(4,078)	(50,026)
Net cash provided by financing activities			(14,429)	(50,277)
Effect of exchange rate changes on cash flows			0	1
Net increase (decrease) in cash			10	1
Cash and cash equivalents at beginning of period			(14)	(10)
Cash and cash equivalents at end of period	(4)	(9)	(4)	(9)
Total Non Guarantors
Operating activities
Net income (loss)	8,501	(17,319)	29,311	(6,986)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Stock-based compensation			184	185
Depreciation			14,995	18,726
Amortization of intangibles			22	79
Deferred financing cost amortization			71	15
Foreign exchange gain on revaluation of debt			0	0
Deferred taxes			(2,232)	853
Asset impairment			1,029	277
Gain on disposition of property and equipment			(116)	(31)
Provision for doubtful accounts			581	118
Undistributed equity in earnings of subsidiaries			0	0
Change in assets and liabilities which provided (used) cash:
Accounts receivable			(2,310)	(4,332)
Inventories			2,417	(8,355)
Prepaid expenses			77	557
Other current assets			(1,773)	1,226
Accounts payable and accrued expenses			1,061	208
Deferred and other long-term liabilities			(6,336)	(3,676)
Intercompany loans			20,104	18,346
Net cash provided by operating activities			57,085	17,210
Investing activities
Capital expenditures			(26,238)	(19,348)
Intercompany property and equipment transfers, net			(8,392)	(13,198)
Proceeds from disposals of property and equipment			75	127
Other Investing Activities				500
Net cash used in investing activities			(34,555)	(31,919)
Financing activities
Net increase in notes payable			6,759
Proceeds from borrowings			20,020	5,636
Principal payments on debt			(11,202)	(5,385)
Dividends paid			(906)
Payment of obligations under capital leases			0	0
Payment of financing fees			45	(775)
Intercompany loans			(32,568)	12,141
Other financing activities			(5,500)
Net cash provided by financing activities			(23,352)	11,617
Effect of exchange rate changes on cash flows			(1,106)	(431)
Net increase (decrease) in cash			(1,928)	(3,523)
Cash and cash equivalents at beginning of period			8,926	21,606
Cash and cash equivalents at end of period	6,998	18,083	6,998	18,083
Other Eliminations
Operating activities
Net income (loss)	(24,591)	26,493	(70,857)	(6,519)
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Stock-based compensation			0	0
Depreciation			0	0
Amortization of intangibles			0	0
Deferred financing cost amortization			0	0
Foreign exchange gain on revaluation of debt			0	0
Deferred taxes			0	0
Asset impairment			0	0
Gain on disposition of property and equipment			0	0
Provision for doubtful accounts			0	0
Undistributed equity in earnings of subsidiaries			59,852	6,661
Change in assets and liabilities which provided (used) cash:
Accounts receivable			0	0
Inventories			149	(142)
Prepaid expenses			0	0
Other current assets			0	0
Accounts payable and accrued expenses			0	0
Deferred and other long-term liabilities			0	0
Intercompany loans			0	0
Net cash provided by operating activities			(10,856)	0
Investing activities
Capital expenditures			0	0
Intercompany property and equipment transfers, net			0	0
Proceeds from disposals of property and equipment			0	0
Other Investing Activities				0
Net cash used in investing activities			0	0
Financing activities
Proceeds from borrowings			0	0
Principal payments on debt			0	0
Dividends paid			10,856
Payment of obligations under capital leases			0	0
Payment of financing fees			0	0
Intercompany loans			0	0
Net cash provided by financing activities			10,856	0
Effect of exchange rate changes on cash flows			0	0
Net increase (decrease) in cash			0	0
Cash and cash equivalents at beginning of period			0	0
Cash and cash equivalents at end of period	$ 0	$ 0	$ 0	$ 0